BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Llovet JM, Vilana R, Brú C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pagès M, Ayuso C. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33:1124-1129. [PMID: 11343240 DOI: 10.1053/jhep.2001.24233] [Cited by in Crossref: 553] [Cited by in F6Publishing: 447] [Article Influence: 27.7] [Reference Citation Analysis]
Number Citing Articles
1 Francica G, de Sio I, Pompili M, Livraghi T. “Wait and see” policy for early hepatocellular carcinoma. Journal of Hepatology 2013;59:635-6. [DOI: 10.1016/j.jhep.2013.04.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Patidar Y, Singhal P, Gupta S, Mukund A, Sarin SK. Radiofrequency ablation of surface v/s intraparenchymal hepatocellular carcinoma in cirrhotic patients. Indian J Radiol Imaging. 2017;27:496-502. [PMID: 29379247 DOI: 10.4103/ijri.ijri_490_16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
3 Livraghi T, Lazzaroni S, Meloni F, Solbiati L. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2005;92:856-858. [PMID: 15892154 DOI: 10.1002/bjs.4986] [Cited by in Crossref: 140] [Cited by in F6Publishing: 105] [Article Influence: 8.8] [Reference Citation Analysis]
4 Hsiao CY, Hu RH, Ho CM, Wu YM, Lee PH, Ho MC. Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center study. Am J Surg 2020;220:958-64. [PMID: 32247523 DOI: 10.1016/j.amjsurg.2020.03.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Nicolau C, Bianchi L, Vilana R. Gray-scale ultrasound in hepatic cirrhosis and chronic hepatitis: diagnosis, screening, and intervention. Semin Ultrasound CT MR. 2002;23:3-18. [PMID: 11866221 DOI: 10.1016/s0887-2171(02)90026-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
6 Melloul E, Lesurtel M, Carr BI, Clavien PA. Developments in liver transplantation for hepatocellular carcinoma. Semin Oncol. 2012;39:510-521. [PMID: 22846868 DOI: 10.1053/j.seminoncol.2012.05.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
7 Suh SW, Lee KW, Lee JM, You T, Choi Y, Kim H, Lee HW, Lee JM, Yi NJ, Suh KS. Prediction of aggressiveness in early-stage hepatocellular carcinoma for selection of surgical resection. J Hepatol. 2014;60:1219-1224. [PMID: 24548529 DOI: 10.1016/j.jhep.2014.01.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
8 Yang YP, Qu JH, Chang XJ, Lu YY, Bai WL, Dong Z, Wang H, An LJ, Xu ZX, Wang CP. High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. J Transl Med. 2013;11:41. [PMID: 23414367 DOI: 10.1186/1479-5876-11-41] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
9 Lencioni R, Crocetti L. Image-guided ablation for hepatocellular carcinoma. Recent Results Cancer Res. 2013;190:181-194. [PMID: 22941021 DOI: 10.1007/978-3-642-16037-0_12] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
10 Miyayama S, Matsui O, Yamashiro M, Ryu Y, Kaito K, Ozaki K, Takeda T, Yoneda N, Notsumata K, Toya D, Tanaka N, Mitsui T. Ultraselective Transcatheter Arterial Chemoembolization with a 2-F Tip Microcatheter for Small Hepatocellular Carcinomas: Relationship Between Local Tumor Recurrence and Visualization of the Portal Vein with Iodized Oil. Journal of Vascular and Interventional Radiology 2007;18:365-76. [DOI: 10.1016/j.jvir.2006.12.004] [Cited by in Crossref: 162] [Cited by in F6Publishing: 136] [Article Influence: 11.6] [Reference Citation Analysis]
11 Casaril A, Abu Hilal M, Harb A, Campagnaro T, Mansueto G, Nicoli N. The safety of radiofrequency thermal ablation in the treatment of liver malignancies. Eur J Surg Oncol. 2008;34:668-672. [PMID: 17681717 DOI: 10.1016/j.ejso.2007.05.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
12 Patt CH, Thuluvath PJ. Role of Liver Transplantation in the Management of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2002;13:S205-10. [DOI: 10.1016/s1051-0443(07)61788-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
13 Miraglia R, Pietrosi G, Maruzzelli L, Petridis I, Caruso S, Marrone G, Mamone G, Vizzini G, Luca A, Gridelli B. Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre-treatment findings. World J Gastroenterol 2007;13:6022-6. [PMID: 18023093 DOI: 10.3748/wjg.v13.45.6022] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
14 Gómez Rodríguez R, Romero Gutiérrez M, González de Frutos C, de Artaza Varasa T, de la Cruz Perez G, Ciampi Dopazo JJ, Lanciego Pérez C, Gómez Moreno AZ. [Clinical characteristics, staging and treatment of patients with hepatocellular carcinoma in clinical practice. Prospective study of 136 patients]. Gastroenterol Hepatol. 2011;34:524-531. [PMID: 21940068 DOI: 10.1016/j.gastrohep.2011.06.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
15 Ryu T, Takami Y, Wada Y, Hara T, Sasaki S, Saitsu H. Hepatic resection versus operative microwave ablation for single hepatocellular carcinoma ≤5 cm: A propensity score-matched analysis. Surgery 2019;166:254-62. [PMID: 31279438 DOI: 10.1016/j.surg.2019.05.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
16 Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002;235:466-86. [PMID: 11923602 DOI: 10.1097/00000658-200204000-00004] [Cited by in Crossref: 300] [Cited by in F6Publishing: 271] [Article Influence: 15.8] [Reference Citation Analysis]
17 Sasaki K, Matsuda M, Ohkura Y, Kawamura Y, Inoue M, Hashimoto M, Ikeda K, Kumada H, Watanabe G. In hepatocellular carcinomas, any proportion of poorly differentiated components is associated with poor prognosis after hepatectomy. World J Surg 2014;38:1147-53. [PMID: 24305929 DOI: 10.1007/s00268-013-2374-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
18 Carrafiello G, Laganà D, Ianniello A, Craparo G, Recaldini C, Lumia D, Dionigi G, Cuffari S, Fugazzola C. Bleeding after percutaneous radiofrequency ablation: Successful treatment with transcatheter embolization. Eur J Radiol. 2007;61:351-355. [PMID: 17097255 DOI: 10.1016/j.ejrad.2006.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
19 Majno PE, Mentha G, Mazzaferro V. Partial hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: Confirming the trial that will never be, and some comments on the indications for liver resection. Hepatology 2010;51:1116-8. [DOI: 10.1002/hep.23648] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
20 Chen TM, Huang PT, Lin LF, Tung JN. Major complications of ultrasound-guided percutaneous radiofrequency ablations for liver malignancies: single center experience. J Gastroenterol Hepatol. 2008;23:e445-e450. [PMID: 17683478 DOI: 10.1111/j.1440-1746.2007.05078.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
21 Schwartz M. Liver transplantation: the preferred treatment for early hepatocellular carcinoma in the setting of cirrhosis? Ann Surg Oncol 2007;14:548-52. [PMID: 17009143 DOI: 10.1245/s10434-006-9157-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
22 Fontana RJ, Hamidullah H, Nghiem H, Greenson JK, Hussain H, Marrero J, Rudich S, McClure LA, Arenas J. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl. 2002;8:1165-1174. [PMID: 12474157 DOI: 10.1053/jlts.2002.36394] [Cited by in Crossref: 117] [Cited by in F6Publishing: 114] [Article Influence: 6.5] [Reference Citation Analysis]
23 Ishikawa T, Zeniya M, Fujise K, Hokari A, Toda G. Clinical application of Nd:YAG laser for the treatment of small hepatocellular carcinoma with new shaped laser probe. Lasers Surg Med. 2004;35:135-139. [PMID: 15334617 DOI: 10.1002/lsm.20071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
24 Rhim H, Dodd GD, Chintapalli KN, Wood BJ, Dupuy DE, Hvizda JL, Sewell PE, Goldberg SN. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics. 2004;24:41-52. [PMID: 14730035 DOI: 10.1148/rg.241025144] [Cited by in Crossref: 213] [Cited by in F6Publishing: 172] [Article Influence: 12.5] [Reference Citation Analysis]
25 Zhang Y, Ding M, Chi JC, Wang T, Shi YP, Zhai B. The early evaluation of ultrasound-guided iodine-125 interstitial implants for high-risk hepatocellular carcinoma. Brachytherapy 2019;18:733-9. [PMID: 31515049 DOI: 10.1016/j.brachy.2019.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Fredericks C, Arslan B, Mullane M, Firfer BL, Chan EY. Needle Tract Seeding Following Irreversible Electroporation (IRE) of Metastatic Colorectal Carcinoma to the Liver. Cardiovasc Intervent Radiol 2015;38:1349-51. [DOI: 10.1007/s00270-015-1124-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
27 Liu K, Chen Y, Wu X, Huang Z, Lin Z, Jiang J, Tan W, Zhang L. Laparoscopic liver re-resection is feasible for patients with posthepatectomy hepatocellular carcinoma recurrence: a propensity score matching study. Surg Endosc 2017;31:4790-8. [DOI: 10.1007/s00464-017-5556-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
28 Belghiti J, Carr BI, Greig PD, Lencioni R, Poon RT. Treatment before liver transplantation for HCC. Ann Surg Oncol. 2008;15:993-1000. [PMID: 18236111 DOI: 10.1245/s10434-007-9787-8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 90] [Article Influence: 6.3] [Reference Citation Analysis]
29 Hänsler J, Neureiter D, Wasserburger M, Janka R, Bernatik T, Schneider T, Müller W, Frieser M, Schaber S, Becker D. Percutaneous US-guided radiofrequency ablation with perfused needle applicators: improved survival with the VX2 tumor model in rabbits. Radiology. 2004;230:169-174. [PMID: 14645878 DOI: 10.1148/radiol.2301021136] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
30 Liu SY, Lee KF, Lai PB. Needle track seeding: a real hazard after percutaneous radiofrequency ablation for colorectal liver metastasis. World J Gastroenterol. 2009;15:1653-1655. [PMID: 19340913 DOI: 10.3748/wjg.15.1653] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
31 Hiltbrand E, Belenger J, Binzoni T, Buchegger F, Fessi H, Costa M, Quash G, Foray J, Mehier H. Thérapie focalisée par micro-injections haute pression à l’aide d’un microtube implantable. ITBM-RBM 2003;24:136-44. [DOI: 10.1016/s1297-9562(03)00006-8] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
32 Espinoza S, Briggs P, Duret J, Lapeyre M, de Baère T. Radiofrequency Ablation of Needle Tract Seeding in Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2005;16:743-6. [DOI: 10.1097/01.rvi.0000153109.56827.70] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
33 Llovet JM. Treatment of hepatocellular carcinoma. Curr Treat Options Gastro 2004;7:431-41. [DOI: 10.1007/s11938-004-0002-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
34 de la Serna S, Vilana R, Sánchez-Cabús S, Calatayud D, Ferrer J, Molina V, Fondevila C, Bruix J, Fuster J, García-Valdecasas JC. Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience. HPB (Oxford). 2015;17:387-393. [PMID: 25545319 DOI: 10.1111/hpb.12379] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
35 Ruzzenente A, Manzoni GD, Molfetta M, Pachera S, Genco B, Donataccio M, Guglielmi A. Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation. World J Gastroenterol. 2004;10:1137-1140. [PMID: 15069713 DOI: 10.3748/wjg.v10.i8.1137] [Cited by in CrossRef: 97] [Cited by in F6Publishing: 88] [Article Influence: 5.7] [Reference Citation Analysis]
36 Gillams AR. The use of radiofrequency in cancer. Br J Cancer 2005;92:1825-9. [PMID: 15870717 DOI: 10.1038/sj.bjc.6602582] [Cited by in Crossref: 90] [Cited by in F6Publishing: 65] [Article Influence: 5.6] [Reference Citation Analysis]
37 Poon RTP. Optimal Initial Treatment for Early Hepatocellular Carcinoma in Patients with Preserved Liver Function: Transplantation or Resection? Ann Surg Oncol 2007;14:541-7. [DOI: 10.1245/s10434-006-9156-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
38 Decker GA, Gores GJ, Roberts LR. Tumor seeding complicating radiofrequency ablation of hepatocellular carcinoma. J Hepatol 2003;38:692. [PMID: 12713885 DOI: 10.1016/s0168-8278(03)00028-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
39 Lin S, Lin C, Chen W, Chen Y, Hsu C. Radiofrequency Ablation for Hepatocellular Carcinoma: A Prospective Comparison of Four Radiofrequency Devices. Journal of Vascular and Interventional Radiology 2007;18:1118-25. [DOI: 10.1016/j.jvir.2007.06.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
40 Gillams AR. Liver ablation therapy. BJR 2004;77:713-23. [DOI: 10.1259/bjr/86761907] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
41 Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, Sarli D, Schiavo M, Garbagnati F, Marchianò A. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg. 2004;240:900-909. [PMID: 15492574 DOI: 10.1097/01.sla.0000143301.56154.95] [Cited by in Crossref: 356] [Cited by in F6Publishing: 314] [Article Influence: 20.9] [Reference Citation Analysis]
42 Torzilli G, Del Fabbro D, Palmisano A, Marconi M, Makuuchi M, Montorsi M. Salvage hepatic resection after incomplete interstitial therapy for primary and secondary liver tumours. Br J Surg. 2007;94:208-213. [PMID: 17149716 DOI: 10.1002/bjs.5603] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
43 Bruix J, Hessheimer AJ, Forner A, Boix L, Vilana R, Llovet JM. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene. 2006;25:3848-3856. [PMID: 16799626 DOI: 10.1038/sj.onc.1209548] [Cited by in Crossref: 109] [Cited by in F6Publishing: 96] [Article Influence: 7.3] [Reference Citation Analysis]
44 Carberry GA, Smolock AR, Cristescu M, Wells SA, Ziemlewicz TJ, Lubner MG, Hinshaw JL, Brace CL, Lee FT. Safety and Efficacy of Percutaneous Microwave Hepatic Ablation Near the Heart. Journal of Vascular and Interventional Radiology 2017;28:490-7. [DOI: 10.1016/j.jvir.2016.12.1216] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
45 Hiraki T, Mimura H, Gobara H, Sano Y, Fujiwara H, Iguchi T, Sakurai J, Kishi R, Kanazawa S. Two Cases of Needle-Tract Seeding after Percutaneous Radiofrequency Ablation for Lung Cancer. Journal of Vascular and Interventional Radiology 2009;20:415-8. [DOI: 10.1016/j.jvir.2008.12.411] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
46 Kaneko H, Tsuchiya M, Otsuka Y, Yajima S, Minagawa T, Watanabe M, Tamura A. Laparoscopic hepatectomy for hepatocellular carcinoma in cirrhotic patients. J Hepatobiliary Pancreat Surg. 2009;16:433-438. [PMID: 19458892 DOI: 10.1007/s00534-009-0123-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
47 Kim DK, Kwon JH, Won JY, Han K, Kim GM, Kim M, Lee DY. Ablation Volume Measurement After Percutaneous Cryoablation Using a Two-cryo-probe Technique for Small Hepatocellular Carcinomas. Cardiovasc Intervent Radiol 2019;42:220-9. [DOI: 10.1007/s00270-018-2084-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Otsuka Y, Tsuchiya M, Maeda T, Katagiri T, Isii J, Tamura A, Yamazaki K, Kubota Y, Suzuki T, Suzuki T. Laparoscopic hepatectomy for liver tumors: proposals for standardization. J Hepatobiliary Pancreat Surg. 2009;16:720-725. [PMID: 19652902 DOI: 10.1007/s00534-009-0139-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
49 Cho YK, Kim JK, Kim WT, Chung JW. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology. 2010;51:1284-1290. [PMID: 20099299 DOI: 10.1002/hep.23466] [Cited by in Crossref: 171] [Cited by in F6Publishing: 135] [Article Influence: 15.5] [Reference Citation Analysis]
50 Chen MH, Yang W, Yan K, Hou YB, Dai Y, Gao W, Zhang H, Wu W. Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach. Abdom Imaging. 2008;33:428-436. [PMID: 17639375 DOI: 10.1007/s00261-007-9283-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
51 Kawamura Y, Ikeda K, Hirakawa M, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F. New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma. Hepatol Res. 2010;40:1006-1014. [PMID: 20887336 DOI: 10.1111/j.1872-034x.2010.00703.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
52 Lencioni R, Llovet JM. Percutaneous ethanol injection for hepatocellular carcinoma: alive or dead? J Hepatol. 2005;43:377-380. [PMID: 16005537 DOI: 10.1016/j.jhep.2005.06.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
53 Filippousis P, Sotiropoulou E, Manataki A, Konstantinopoulos O, Thanos L. Radiofrequency ablation of subcapsular hepatocellular carcinoma: Single center experience. European Journal of Radiology 2011;77:299-304. [DOI: 10.1016/j.ejrad.2009.07.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
54 Liang P, Wang Y, Yu X, Dong B. Malignant Liver Tumors: Treatment with Percutaneous Microwave Ablation—Complications among Cohort of 1136 Patients. Radiology 2009;251:933-40. [DOI: 10.1148/radiol.2513081740] [Cited by in Crossref: 211] [Cited by in F6Publishing: 179] [Article Influence: 17.6] [Reference Citation Analysis]
55 Goldberg SN, Solbiati L. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001;34:609; author reply 610-1. [PMID: 11526553 DOI: 10.1002/hep.510340327] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
56 Solmi L, Nigro G, Roda E. Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma. World J Gastroenterol 2006;12:1098-104. [PMID: 16534852 DOI: 10.3748/wjg.v12.i7.1098] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
57 McDermott S, Gervais DA. Radiofrequency ablation of liver tumors. Semin Intervent Radiol. 2013;30:49-55. [PMID: 24436517 DOI: 10.1055/s-0033-1333653] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 7.1] [Reference Citation Analysis]
58 Cantamessa A, Brunocilla PR, Carucci P, Bruno M, Gaia S, Brizzi RF, Spandre M, Pacchioni D, Campione A, Rizzetto M, De Angelis C. Endoscopic ultrasound-guided fine needle aspiration in the diagnosis of pelvic metastasis of hepatocellular carcinoma: case report and review of literature. J Gastrointest Cancer 2013;44:238-40. [PMID: 23054579 DOI: 10.1007/s12029-012-9440-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Chang W, Lee JM, Lee SM, Han JK. No-Touch Radiofrequency Ablation: A Comparison of Switching Bipolar and Switching Monopolar Ablation in Ex Vivo Bovine Liver. Korean J Radiol 2017;18:279-88. [PMID: 28246508 DOI: 10.3348/kjr.2017.18.2.279] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
60 Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. The Lancet 2003;362:1907-17. [DOI: 10.1016/s0140-6736(03)14964-1] [Cited by in Crossref: 3076] [Cited by in F6Publishing: 1246] [Article Influence: 170.9] [Reference Citation Analysis]
61 Yamamoto N, Okano K, Kushida Y, Deguchi A, Yachida S, Suzuki Y. Clinicopathology of recurrent hepatocellular carcinomas after radiofrequency ablation treated with salvage surgery. Hepatol Res. 2014;44:1062-1071. [PMID: 23957810 DOI: 10.1111/hepr.12223] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
62 Cao W, Lu Q, Li JH, Zhou CX, Zhu J, Wan Y, Liu YF. Transcatheter arterial infusion with heated saline changes the vascular permeability of rabbit hepatic tumors. Acad Radiol 2011;18:1569-76. [PMID: 21968263 DOI: 10.1016/j.acra.2011.08.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
63 Rempp H, Boss A, Helmberger T, Pereira P. The current role of minimally invasive therapies in the management of liver tumors. Abdom Imaging. 2011;36:635-647. [PMID: 21562884 DOI: 10.1007/s00261-011-9749-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
64 Miyayama S, Mitsui T, Zen Y, Sudo Y, Yamashiro M, Okuda M, Yoshie Y, Sanada T, Notsumata K, Tanaka N. Histopathological findings after ultraselective transcatheter arterial chemoembolization for hepatocellular carcinoma. Hepatol Res. 2009;39:374-381. [PMID: 19054146 DOI: 10.1111/j.1872-034x.2008.00465.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
65 Wong SN, Lin CJ, Lin CC, Chen WT, Cua IH, Lin SM. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. AJR Am J Roentgenol. 2008;190:W187-W195. [PMID: 18287411 DOI: 10.2214/ajr.07.2537] [Cited by in Crossref: 57] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
66 Chang S, Kim SH, Lim HK, Kim SH, Lee WJ, Choi D, Kim YS, Rhim H. Needle tract implantation after percutaneous interventional procedures in hepatocellular carcinomas: lessons learned from a 10-year experience. Korean J Radiol. 2008;9:268-274. [PMID: 18525230 DOI: 10.3348/kjr.2008.9.3.268] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
67 Izzo F, Palaia R, Albino V, Amore A, di Giacomo R, Piccirillo M, Leongito M, Nasto A, Granata V, Petrillo A, Lastoria S. Hepatocellular carcinoma and liver metastases: clinical data on a new dual-lumen catheter kit for surgical sealant infusion to prevent perihepatic bleeding and dissemination of cancer cells following biopsy and loco-regional treatments. Infect Agent Cancer 2015;10:11. [PMID: 25897320 DOI: 10.1186/s13027-015-0006-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
68 Miyayama S, Matsui O, Yamashiro M, Ryu Y, Takata H, Takeda T, Aburano H, Shigenari N. Iodized oil accumulation in the hypovascular tumor portion of early-stage hepatocellular carcinoma after ultraselective transcatheter arterial chemoembolization. Hepatol Int. 2007;1:451-459. [PMID: 19669342 DOI: 10.1007/s12072-007-9030-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
69 Sala M, Varela M, Bruix J. Selection of candidates with HCC for transplantation in the MELD era. Liver Transpl. 2004;10:S4-S9. [PMID: 15382217 DOI: 10.1002/lt.20263] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
70 Lencioni R, Crocetti L. Radiofrequency Ablation of Liver Cancer. Techniques in Vascular and Interventional Radiology 2007;10:38-46. [DOI: 10.1053/j.tvir.2007.08.006] [Cited by in Crossref: 71] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
71 Lubienski A. Radiofrequency Ablation in Metastatic Disease. In: Büchler MW, Weitz J, Ulrich B, Heald RJ, editors. Rectal Cancer Treatment. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 268-76. [DOI: 10.1007/3-540-27449-9_30] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
72 Kwak MS, Lee JH, Yoon JH, Yu SJ, Cho EJ, Jang ES, Kim YJ, Lee HS. Risk factors, clinical features, and prognosis of the hepatocellular carcinoma with peritoneal metastasis. Dig Dis Sci. 2012;57:813-819. [PMID: 22147252 DOI: 10.1007/s10620-011-1995-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
73 Kwon H, Kim PN, Byun JH, Kim KW, Won HJ, Shin YM, Lee M. Various complications of percutaneous radiofrequency ablation for hepatic tumors: radiologic findings and technical tips. Acta Radiol 2014;55:1082-92. [DOI: 10.1177/0284185113513893] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
74 Masuda T, Beppu T, Ishiko T, Horino K, Baba Y, Mizumoto T, Hayashi H, Okabe H, Horlad H, Doi K. Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy. J Hepatobiliary Pancreat Surg. 2008;15:589-595. [PMID: 18987928 DOI: 10.1007/s00534-007-1288-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
75 Hong K, Georgiades CS, Geschwind JF. Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques. Nat Clin Pract Oncol. 2006;3:315-324. [PMID: 16757969 DOI: 10.1038/ncponc0512] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
76 Cho YK, Rhim H, Ahn YS, Kim MY, Lim HK. Percutaneous Radiofrequency Ablation Therapy of Hepatocellular Carcinoma Using Multitined Expandable Electrodes: Comparison of Subcapsular and Nonsubcapsular Tumors. American Journal of Roentgenology 2006;186:S269-74. [DOI: 10.2214/ajr.04.1346] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
77 Kim AY, Rhim H, Park M, Lee MW, Kim YS, Choi D, Lim HK. Venous thrombosis after radiofrequency ablation for hepatocellular carcinoma. AJR Am J Roentgenol. 2011;197:1474-1480. [PMID: 22109305 DOI: 10.2214/ajr.11.6495] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 2.1] [Reference Citation Analysis]
78 Webb H, Lubner MG, Hinshaw JL. Thermal ablation. Semin Roentgenol. 2011;46:133-141. [PMID: 21338838 DOI: 10.1053/j.ro.2010.08.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
79 Seror O, N'kontchou G, Tin-tin-htar M, Barrucand C, Ganne N, Coderc E, Trinchet JC, Sellier N, Beaugrand M. Radiofrequency Ablation with Internally Cooled versus Perfused Electrodes for the Treatment of Small Hepatocellular Carcinoma in Patients with Cirrhosis. Journal of Vascular and Interventional Radiology 2008;19:718-24. [DOI: 10.1016/j.jvir.2008.01.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
80 Nguyen MH, Keeffe EB. General management. Best Practice & Research Clinical Gastroenterology 2005;19:161-74. [DOI: 10.1016/j.bpg.2004.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
81 Ng KK, Poon RT. Radiofrequency ablation for malignant liver tumor. Surg Oncol. 2005;14:41-52. [PMID: 15777889 DOI: 10.1016/j.suronc.2005.01.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
82 Sartori S, Tombesi P, Macario F, Nielsen I, Tassinari D, Catellani M, Abbasciano V. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Radiology. 2008;248:670-679. [PMID: 18519740 DOI: 10.1148/radiol.2482071690] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
83 Crocetti L, Bargellini I, Cioni R. Loco-regional treatment of HCC: current status. Clin Radiol. 2017;72:626-635. [PMID: 28258743 DOI: 10.1016/j.crad.2017.01.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
84 Iida H, Tani M, Aihara T, Hasegawa K, Eguchi H, Tanabe M, Yamamoto M, Yamaue H. New metastasectomy criteria for peritoneal metastasis of hepatocellular carcinoma: A study of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2020;27:673-81. [DOI: 10.1002/jhbp.796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
85 Shields A, Reddy KR. Hepatocellular carcinoma: current treatment strategies. Curr Treat Options Gastroenterol 2005;8:457-66. [PMID: 16313863 DOI: 10.1007/s11938-005-0032-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
86 Sala M, Llovet JM, Vilana R, Bianchi L, Solé M, Ayuso C, Brú C, Bruix J; for the Barcelona Cly'nic Liver Cancer (BCLC) Group. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004;40:1352-60. [DOI: 10.1002/hep.20465] [Cited by in Crossref: 330] [Cited by in F6Publishing: 280] [Article Influence: 19.4] [Reference Citation Analysis]
87 Yang W, Yan K, Wu GX, Wu W, Fu Y, Lee JC, Zhang ZY, Wang S, Chen MH. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes. World J Gastroenterol. 2015;21:1554-1566. [PMID: 25663774 DOI: 10.3748/wjg.v21.i5.1554] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
88 West KL, Selim MA, Puri PK. Cutaneous metastatic cholangiocarcinoma: a report of three cases and review of the literature. J Cutan Pathol. 2010;37:1230-1236. [PMID: 20883451 DOI: 10.1111/j.1600-0560.2010.01619.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
89 Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol. 2005;31:331-347. [PMID: 15837037 DOI: 10.1016/j.ejso.2004.10.011] [Cited by in Crossref: 93] [Cited by in F6Publishing: 78] [Article Influence: 5.8] [Reference Citation Analysis]
90 Qin H, Gao P, Wang F, Zhao L, Zhu J, Wang A, Zhang T, Wu R, Zou H. Highly Efficient Extraction of Serum Peptides by Ordered Mesoporous Carbon. Angew Chem 2011;123:12426-9. [DOI: 10.1002/ange.201103666] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
91 Krasnick BA, Sindram D, Simo K, Goss R, Bharadwaj J, Howk K, Herdina KA, Hammill CW. Tumor Ablation Using 3-Dimensional Electromagnetic-Guided Ultrasound Versus Standard Ultrasound in a Porcine Model. Surg Innov 2019;26:420-6. [DOI: 10.1177/1553350619825717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Lee FT Jr, Haemmerich D, Wright AS, Mahvi DM, Sampson LA, Webster JG. Multiple probe radiofrequency ablation: pilot study in an animal model. J Vasc Interv Radiol 2003;14:1437-42. [PMID: 14605110 DOI: 10.1097/01.rvi.0000096771.74047.c8] [Cited by in Crossref: 55] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
93 Kawamura Y, Ikeda K, Fujiyama S, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H. Potential of a no-touch pincer ablation procedure that uses a multipolar radiofrequency ablation system to prevent intrasubsegmental recurrence of small and single hepatocellular carcinomas. Hepatol Res 2017;47:1008-20. [PMID: 27862748 DOI: 10.1111/hepr.12838] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
94 Hasegawa K, Kokudo N, Sano K, Makuuchi M. Single HCC between 2 and 5 cm: the grey zone: surgeon's perspective. J Hepatobiliary Pancreat Sci 2010;17:430-3. [PMID: 19890599 DOI: 10.1007/s00534-009-0245-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
95 Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST, Wong J. Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg. 2004;239:441-449. [PMID: 15024304 DOI: 10.1097/01.sla.0000118565.21298.0a] [Cited by in Crossref: 146] [Cited by in F6Publishing: 122] [Article Influence: 8.6] [Reference Citation Analysis]
96 Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev. 2007;33:437-447. [PMID: 17512669 DOI: 10.1016/j.ctrv.2007.04.001] [Cited by in Crossref: 198] [Cited by in F6Publishing: 159] [Article Influence: 14.1] [Reference Citation Analysis]
97 Giorgio A, Tarantino L, de Stefano G, Coppola C, Ferraioli G. Complications After Percutaneous Saline-Enhanced Radiofrequency Ablation of Liver Tumors: 3-Year Experience with 336 Patients at a Single Center. American Journal of Roentgenology 2005;184:207-11. [DOI: 10.2214/ajr.184.1.01840207] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 4.8] [Reference Citation Analysis]
98 Francica G, Meloni MF, de Sio I, Smolock AR, Brace CL, Iadevaia MD, Santambrogio R, Sironi S, Scaglione M, Lee Jr. FT. Radiofrequency and microwave ablation of subcapsular hepatocellular carcinoma accessed by direct puncture: Safety and efficacy. European Journal of Radiology 2016;85:739-43. [DOI: 10.1016/j.ejrad.2016.01.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
99 Tarantino L, Sordelli I, Nocera V, Piscopo A, Ripa C, Parmeggiani D, Sperlongano P. Ablation of large HCCs using a new saline-enhanced expandable radiofrequency device(). J Ultrasound 2009;12:69-74. [PMID: 23396886 DOI: 10.1016/j.jus.2009.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
100 Kuvshinoff BW, Ota DM. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery. 2002;132:605-611; discussion 611-612. [PMID: 12407343 DOI: 10.1067/msy.2002.127545] [Cited by in Crossref: 152] [Cited by in F6Publishing: 130] [Article Influence: 8.0] [Reference Citation Analysis]
101 Girotra M, Soota K, Dhaliwal AS, Abraham RR, Garcia-Saenz-de-Sicilia M, Tharian B. Utility of endoscopic ultrasound and endoscopy in diagnosis and management of hepatocellular carcinoma and its complications: What does endoscopic ultrasonography offer above and beyond conventional cross-sectional imaging? World J Gastrointest Endosc. 2018;10:56-68. [PMID: 29467916 DOI: 10.4253/wjge.v10.i2.56] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
102 Bolondi L, Piscaglia F, Camaggi V, Grazi GL, Cavallari A. Review article: liver transplantation for HCC. Treatment options on the waiting list. Aliment Pharmacol Ther. 2003;17 Suppl 2:145-150. [PMID: 12786626 DOI: 10.1046/j.1365-2036.17.s2.8.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
103 Lubienski A. Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation. 2005;80:S113-S119. [PMID: 16286887 DOI: 10.1097/01.tp.0000187109.69663.93] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
104 Cheung TT, Ng KK, Chok KS, Chan SC, Poon RT, Lo CM, Fan ST. Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes. World J Gastroenterol. 2010;16:3056-3062. [PMID: 20572310 DOI: 10.3748/wjg.v16.i24.3056] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
105 Majno P, Giostra E, Morel P, Hadengue A, Mentha G. Management of hepatocellular carcinoma in the waiting list before liver transplantation. Journal of Hepatology 2005;42:S134-43. [DOI: 10.1016/j.jhep.2004.12.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
106 Takemura N, Hasegawa K, Aoki T, Sakamoto Y, Sugawara Y, Makuuchi M, Kokudo N. Surgical resection of peritoneal or thoracoabdominal wall implants from hepatocellular carcinoma. Br J Surg. 2014;101:1017-1022. [PMID: 24828028 DOI: 10.1002/bjs.9489] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
107 Morimoto M, Numata K, Kondo M, Moriya S, Morita S, Maeda S, Tanaka K. Radiofrequency ablation combined with transarterial chemoembolization for subcapsular hepatocellular carcinoma: a prospective cohort study. Eur J Radiol. 2013;82:497-503. [PMID: 23068563 DOI: 10.1016/j.ejrad.2012.09.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
108 Durand F, Belghiti J, Paradis V. Liver transplantation for hepatocellular carcinoma: role of biopsy. Liver Transpl. 2007;13:S17-S23. [PMID: 17969095 DOI: 10.1002/lt.21326] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
109 Abdo AA, Hassanain M, AlJumah A, Al Olayan A, Sanai FM, Alsuhaibani HA, Abdulkareem H, Abdallah K, AlMuaikeel M, Al Saghier M, Babatin M, Kabbani M, Bazarbashi S, Metrakos P, Bruix J; Saudi Association for the Study of Liver Diseases and Transplantation., Saudi Oncology Society. Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines. Ann Saudi Med 2012;32:174-99. [PMID: 22366832 DOI: 10.5144/0256-4947.2012.174] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
110 Francica G, Petrolati A, Di Stasio E, Pacella S, Stasi R, Pacella CM. Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location. AJR Am J Roentgenol. 2012;199:1393-1401. [PMID: 23169736 DOI: 10.2214/ajr.11.7850] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
111 Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology. 2008;247:311-330. [PMID: 18430871 DOI: 10.1148/radiol.2472061331] [Cited by in Crossref: 274] [Cited by in F6Publishing: 227] [Article Influence: 21.1] [Reference Citation Analysis]
112 Kawamoto C, Yamauchi A, Baba Y, Kaneko K, Yakabi K. Measurement of intrahepatic pressure during radiofrequency ablation in porcine liver. J Gastroenterol 2010;45:435-42. [DOI: 10.1007/s00535-009-0156-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
113 Gillams AR. Complications of percutaneous therapy. Cancer Imaging 2005;5:110-3. [PMID: 16305947 DOI: 10.1102/1470-7330.2005.0017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
114 Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging. 2005;30:409-418. [PMID: 15688113 DOI: 10.1007/s00261-004-0255-7] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 6.0] [Reference Citation Analysis]
115 Morise Z. Developments and perspectives of laparoscopic liver resection in the treatment of hepatocellular carcinoma. Surg Today 2019;49:649-55. [PMID: 30649611 DOI: 10.1007/s00595-019-1765-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
116 Kettenbach J, Köstler W, Rücklinger E, Gustorff B, Hüpfl M, Wolf F, Peer K, Weigner M, Lammer J, Müller W. Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. AJR Am J Roentgenol. 2003;180:1537-1545. [PMID: 12760914 DOI: 10.2214/ajr.180.6.1801537] [Cited by in Crossref: 112] [Cited by in F6Publishing: 87] [Article Influence: 6.2] [Reference Citation Analysis]
117 Takahashi S, Chung H, Kitai S, Inoue T, Minami Y, Ueshima K, Kudo M. Foreign body granuloma mimicking disseminated tumour recurrence after radiofrequency ablation for hepatocellular carcinoma: Letters to the Editor. Liver International 2008;28:414-5. [DOI: 10.1111/j.1478-3231.2007.01607.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
118 Fong ZV, Tanabe KK. The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: A comprehensive and evidence-based comparison and review: Review of International HCC Guidelines. Cancer 2014;120:2824-38. [DOI: 10.1002/cncr.28730] [Cited by in Crossref: 153] [Cited by in F6Publishing: 146] [Article Influence: 21.9] [Reference Citation Analysis]
119 Cheung TT, Ma KW, She WH. A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis. Hepatobiliary Surg Nutr 2021;10:193-209. [PMID: 33898560 DOI: 10.21037/hbsn.2020.03.11] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Popilski H, Abtew E, Schwendeman S, Domb A, Stepensky D. Efficacy of paclitaxel/dexamethasone intra-tumoral delivery in treating orthotopic mouse breast cancer. J Control Release 2018;279:1-7. [PMID: 29654797 DOI: 10.1016/j.jconrel.2018.04.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
121 Morimoto M, Numata K, Sugimori K, Shirato K, Kokawa A, Oka H, Hirasawa K, Koh R, Nihommatsu H, Tanaka K. Successful initial ablation therapy contributes to survival in patients with hepatocellular carcinoma. World J Gastroenterol 2007;13:1003-9. [PMID: 17373733 DOI: 10.3748/wjg.v13.i7.1003] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
122 Nemcek AA. Complications of radiofrequency ablation of neoplasms. Semin Intervent Radiol. 2006;23:177-187. [PMID: 21326761 DOI: 10.1055/s-2006-941448] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
123 Rong G, Bai W, Dong Z, Wang C, Lu Y, Zeng Z, Qu J, Lou M, Wang H, Gao X, Chang X, An L, Chen Y, Yang Y. Cryotherapy for cirrhosis-based hepatocellular carcinoma: a single center experience from 1595 treated cases. Front Med 2015;9:63-71. [DOI: 10.1007/s11684-014-0342-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
124 Kim JW, Shin SS, Heo SH, Hong JH, Lim HS, Seon HJ, Hur YH, Park CH, Jeong YY, Kang HK. Ultrasound-Guided Percutaneous Radiofrequency Ablation of Liver Tumors: How We Do It Safely and Completely. Korean J Radiol 2015;16:1226-39. [PMID: 26576111 DOI: 10.3348/kjr.2015.16.6.1226] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
125 Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Dong BW. Needle track seeding after percutaneous microwave ablation of malignant liver tumors under ultrasound guidance: analysis of 14-year experience with 1462 patients at a single center. Eur J Radiol. 2012;81:2495-2499. [PMID: 22137097 DOI: 10.1016/j.ejrad.2011.10.019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
126 Hänsler J, Frieser M, Schaber S, Kutschall C, Bernatik T, Müller W, Becker D, Hahn EG, Strobel D. Radiofrequency ablation of hepatocellular carcinoma with a saline solution perfusion device: a pilot study. J Vasc Interv Radiol. 2003;14:575-580. [PMID: 12761310 DOI: 10.1097/01.rvi.0000071096.76348.3b] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
127 Padma S, Martinie JB, Iannitti DA. Liver tumor ablation: Percutaneous and open approaches. J Surg Oncol. 2009;100:619-634. [PMID: 20017157 DOI: 10.1002/jso.21364] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 6.2] [Reference Citation Analysis]
128 Nagarajan VK, Ward JM, Yu B. Association of Liver Tissue Optical Properties and Thermal Damage. Lasers Surg Med 2020;52:779-87. [PMID: 31919868 DOI: 10.1002/lsm.23209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
129 McDevitt JL, Collard MD, Murphy RP, Sutphin PD, Yopp AC, Singal AG, Kalva SP. Comparison of radiofrequency and microwave ablation and identification of risk factors for primary treatment failure and local progression. Clin Imaging 2020;67:146-51. [PMID: 32659600 DOI: 10.1016/j.clinimag.2020.06.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
130 Ohki T, Tateishi R, Shiina S, Sato T, Masuzaki R, Yoshida H, Kanai F, Obi S, Yoshida H, Omata M. Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma. Liver Int 2007;27:360-7. [DOI: 10.1111/j.1478-3231.2006.01420.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
131 Fartoux L, Arrive L, Andreani T, Serfaty L, Chazouillères O, Tubiana J, Poupon R, Rosmorduc O. Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. Gastroentérologie Clinique et Biologique 2005;29:1213-9. [DOI: 10.1016/s0399-8320(05)82203-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
132 Ikushima I, Higashi S, Ishii A, Seguchi K, Iryo Y, Ota Y, Shima M. Transcatheter Infusion of Epirubicin in Water-in-Oil-in-Water Emulsion via a Cystic Artery for the Treatment of Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 2011;34:802-7. [DOI: 10.1007/s00270-010-9988-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
133 Giorgio A, Tarantino L, de Stefano G, Francica G, Esposito F, Perrotta A, Aloisio V, Farella N, Mariniello N, Coppola C. Complications after interventional sonography of focal liver lesions: a 22-year single-center experience. J Ultrasound Med. 2003;22:193-205. [PMID: 12562124 DOI: 10.7863/jum.2003.22.2.193] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
134 Seppenwoolde Y, Wunderink W, Wunderink-van Veen SR, Storchi P, Méndez Romero A, Heijmen BJ. Treatment precision of image-guided liver SBRT using implanted fiducial markers depends on marker-tumour distance. Phys Med Biol. 2011;56:5445-5468. [PMID: 21813963 DOI: 10.1088/0031-9155/56/17/001] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 7.0] [Reference Citation Analysis]
135 Yao F, Terrault N. Hepatitis C and hepatocellular carcinoma. Curr Treat Options in Oncol 2001;2:473-83. [DOI: 10.1007/s11864-001-0069-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
136 Worm ES, Bertholet J, Høyer M, Fledelius W, Hansen AT, Larsen LP, Nielsen JE, Poulsen PR. Fiducial marker guided stereotactic liver radiotherapy: Is a time delay between marker implantation and planning CT needed? Radiotherapy and Oncology 2016;121:75-8. [DOI: 10.1016/j.radonc.2016.07.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
137 Smolock AR, Shaw C. Hepatic Microwave Ablation in Challenging Locations. Semin Intervent Radiol 2019;36:392-7. [PMID: 31798213 DOI: 10.1055/s-0039-1697003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
138 Chang W, Lee JM, Yoon JH, Lee DH, Lee SM, Lee KB, Kim BR, Kim TH, Lee S, Han JK. No-touch radiofrequency ablation using multiple electrodes: An in vivo comparison study of switching monopolar versus switching bipolar modes in porcine livers. PLoS One 2017;12:e0176350. [PMID: 28445542 DOI: 10.1371/journal.pone.0176350] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
139 de Baère T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T, Din MGE, Letoublon C, Elias D. Adverse Events During Radiofrequency Treatment of 582 Hepatic Tumors. American Journal of Roentgenology 2003;181:695-700. [DOI: 10.2214/ajr.181.3.1810695] [Cited by in Crossref: 352] [Cited by in F6Publishing: 279] [Article Influence: 19.6] [Reference Citation Analysis]
140 Guan YS, Sun L, Zhou XP, Li X, Zheng XH. Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up. World J Gastroenterol. 2004;10:3543-3548. [PMID: 15534903 DOI: 10.3748/wjg.v10.i24.3543] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
141 Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol. 2011;21:2584-2596. [PMID: 21858539 DOI: 10.1007/s00330-011-2222-3] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 9.1] [Reference Citation Analysis]
142 Sofocleous CT, Klein KM, Hubbi B, Brown KT, Weiss SH, Kannarkat G, Hinrichs CR, Contractor D, Bahramipour P, Barone A, Baker SR. Histopathologic evaluation of tissue extracted on the radiofrequency probe after ablation of liver tumors: preliminary findings. AJR Am J Roentgenol 2004;183:209-13. [PMID: 15208140 DOI: 10.2214/ajr.183.1.1830209] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
143 Mancuso A. Management of hepatocellular carcinoma: Enlightening the gray zones. World J Hepatol. 2013;5:302-310. [PMID: 23805354 DOI: 10.4254/wjh.v5.i6.302] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
144 Mima K, Hayashi H, Imai K, Kuroki H, Nakagawa S, Okabe H, Chikamoto A, Watanabe M, Beppu T, Baba H. High CD44s expression is associated with the EMT expression profile and intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy. J Hepatobiliary Pancreat Sci. 2013;20:429-434. [PMID: 23238743 DOI: 10.1007/s00534-012-0580-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
145 Ng KK, Lam CM, Poon RT, Ai V, Tso WK, Fan ST. Thermal ablative therapy for malignant liver tumors: a critical appraisal. J Gastroenterol Hepatol. 2003;18:616-629. [PMID: 12753142 DOI: 10.1046/j.1440-1746.2003.02991.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
146 Jaskolka JD, Asch MR, Kachura JR, Ho CS, Ossip M, Wong F, Sherman M, Grant DR, Greig PD, Gallinger S. Needle Tract Seeding after Radiofrequency Ablation of Hepatic Tumors. Journal of Vascular and Interventional Radiology 2005;16:485-91. [DOI: 10.1097/01.rvi.0000151141.09597.5f] [Cited by in Crossref: 109] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
147 Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol. 2006;17:1251-1278. [PMID: 16923973 DOI: 10.1097/01.rvi.0000233785.75257.9a] [Cited by in Crossref: 457] [Cited by in F6Publishing: 120] [Article Influence: 30.5] [Reference Citation Analysis]
148 Bimonte S, Barbieri A, Palaia R, Leongito M, Albino V, Piccirillo M, Arra C, Izzo F. An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma. Infect Agent Cancer 2015;10:9. [PMID: 25755676 DOI: 10.1186/s13027-015-0004-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
149 Chan AC, Chan SC, Chok KS, Cheung TT, Chiu DW, Poon RT, Fan ST, Lo CM. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? Liver Transpl. 2013;19:411-419. [PMID: 23447460 DOI: 10.1002/lt.23605] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 8.8] [Reference Citation Analysis]
150 Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, Tso WK, Fan ST, Poon RT. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg. 2008;207:20-29. [PMID: 18589357 DOI: 10.1016/j.jamcollsurg.2008.01.020] [Cited by in Crossref: 121] [Cited by in F6Publishing: 113] [Article Influence: 9.3] [Reference Citation Analysis]
151 Lee DH, Lee JM. Recent Advances in the Image-Guided Tumor Ablation of Liver Malignancies: Radiofrequency Ablation with Multiple Electrodes, Real-Time Multimodality Fusion Imaging, and New Energy Sources. Korean J Radiol 2018;19:545-59. [PMID: 29962861 DOI: 10.3348/kjr.2018.19.4.545] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
152 Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology. 2002;122:1609-1619. [PMID: 12016426 DOI: 10.1053/gast.2002.33411] [Cited by in Crossref: 374] [Cited by in F6Publishing: 352] [Article Influence: 19.7] [Reference Citation Analysis]
153 Ding J, Zhou Y, Wang Y, Jing X, Wang F, Wang Y. Percutaneous microwave ablation of exophytic tumours in hepatocellular carcinoma patients: Safe or not? Liver Int 2017;37:1365-72. [DOI: 10.1111/liv.13426] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
154 Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 2007;72 Suppl 1:98-103. [PMID: 18087189 DOI: 10.1159/000111714] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 5.1] [Reference Citation Analysis]
155 Mori Y, Tamai H, Shingaki N, Moribata K, Shiraki T, Deguchi H, Ueda K, Enomoto S, Magari H, Inoue I. Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma. Hepatol Int. 2009;3:509-515. [PMID: 19669252 DOI: 10.1007/s12072-009-9131-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
156 Huo TI, Huang YH, Wu JC. Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives. J Chin Med Assoc 2005;68:155-9. [PMID: 15850062 DOI: 10.1016/S1726-4901(09)70239-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
157 Real M, Bianchi L, Vilana R, Burrel M, Rimola J. Tratamiento percutáneo e intraarterial del carcinoma hepatocelular. Radiología 2010;52:399-413. [DOI: 10.1016/j.rx.2010.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
158 Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg. 2009;249:20-25. [PMID: 19106671 DOI: 10.1097/sla.0b013e31818eec29] [Cited by in Crossref: 216] [Cited by in F6Publishing: 79] [Article Influence: 18.0] [Reference Citation Analysis]
159 Hashimoto M, Sasaki K, Moriyama J, Matsuda M, Watanabe G. Resection of peritoneal metastases in patients with hepatocellular carcinoma. Surgery. 2013;153:727-731. [PMID: 22705249 DOI: 10.1016/j.surg.2012.03.031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
160 Bruix J, Sherman M;  Practice Guidelines Committee;  American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236. [PMID: 16250051 DOI: 10.1002/hep.20933] [Cited by in Crossref: 4104] [Cited by in F6Publishing: 3775] [Article Influence: 256.5] [Reference Citation Analysis]
161 Nakamura M, Hayami S, Ueno M, Kawai M, Miyamoto A, Suzaki N, Hirono S, Okada KI, Miyazawa M, Kitahata Y, Yamaue H. Detection of needle tract implantation and peritoneal seeding after radiofrequency ablation using intraoperative near-infrared fluorescence system for recurrent hepatocellular carcinoma: a case report. Surg Case Rep 2018;4:76. [PMID: 30003446 DOI: 10.1186/s40792-018-0485-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
162 Schmilovitz-weiss H, Stemmer S, Liberzon E, Avigad S, Sulkes J, Belinki A, Kazatsker A, Ben-ari Z. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: A prospective pilot study. Cancer Detection and Prevention 2006;30:204-9. [DOI: 10.1016/j.cdp.2005.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
163 Park SI, Kim IJ, Lee SJ, Shin MW, Shin WS, Chung YE, Kim GM, Kim MD, Won JY, Lee do Y, Choi JS, Han KH. Angled Cool-Tip Electrode for Radiofrequency Ablation of Small Superficial Subcapsular Tumors in the Liver: A Feasibility Study. Korean J Radiol 2016;17:742-9. [PMID: 27587963 DOI: 10.3348/kjr.2016.17.5.742] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
164 Sainani NI, Gervais DA, Mueller PR, Arellano RS. Imaging after percutaneous radiofrequency ablation of hepatic tumors: Part 2, Abnormal findings. AJR Am J Roentgenol. 2013;200:194-204. [PMID: 23255762 DOI: 10.2214/ajr.12.8479] [Cited by in Crossref: 44] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
165 Liu PH, Hsu CY, Hsia CY, Lee YH, Huang YH, Chiou YY, Lin HC, Huo TI. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model. Ann Surg 2016;263:538-45. [PMID: 25775062 DOI: 10.1097/SLA.0000000000001178] [Cited by in Crossref: 86] [Cited by in F6Publishing: 46] [Article Influence: 17.2] [Reference Citation Analysis]
166 Cabibbo G, Latteri F, Antonucci M, Craxì A. Multimodal approaches to the treatment of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2009;6:159-69. [DOI: 10.1038/ncpgasthep1357] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
167 Wang CP, Wang H, Qu JH, Lu YY, Bai WL, Dong Z, Gao XD, Rong GH, Zeng Z, Yang YP. Tumour seeding after percutaneous cryoablation for hepatocellular carcinoma. World J Gastroenterol. 2012;18:6587-6596. [PMID: 23236233 DOI: 10.3748/wjg.v18.i45.6587] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
168 Wang F, Ma J, Wu L, Li N, Luo R, Wei G, Yang J. Percutaneous cryoablation of subcapsular hepatocellular carcinoma: a retrospective study of 57 cases. Diagn Interv Radiol 2020;26:34-9. [PMID: 31650975 DOI: 10.5152/dir.2019.18543] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
169 Tajima H, Ohta T, Okamoto K, Nakanuma S, Hayashi H, Nakagawara H, Onishi I, Takamura H, Kitagawa H, Fushida S, Tani T, Fujimura T, Kayahara M, Arai K, Yamashita T, Kaneko S, Zen Y. Radiofrequency ablation induces dedifferentiation of hepatocellular carcinoma. Oncol Lett. 2010;1:91-94. [PMID: 22966262 DOI: 10.3892/ol_00000016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
170 Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, De Wever I, Michel L. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;89:1206-1222. [PMID: 12296886 DOI: 10.1046/j.1365-2168.2002.02168.x] [Cited by in Crossref: 529] [Cited by in F6Publishing: 429] [Article Influence: 27.8] [Reference Citation Analysis]
171 Sato K, Watanabe Y, Horiuchi A, Yukumi S, Doi T, Yoshida M, Yamamoto Y, Tsunooka N, Kawachi K. Feasibility of New Heating Method of Hepatic Parenchyma Using a Sintered MgFe2O4 Needle Under an Alternating Magnetic Field. Journal of Surgical Research 2008;146:110-6. [DOI: 10.1016/j.jss.2007.05.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
172 Kettenbach J, Blum M, Kilanowicz E, Schwaighofer SM, Lammer J. [Percutaneous radiofrequency ablation of liver cell carcinoma: a current overview]. Radiologe. 2004;44:330-338. [PMID: 15045198 DOI: 10.1007/s00117-004-1031-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
173 Hung KC, Yang KL, Huang GC, Chen YF, Chang WT, Chuang CC. Cytoreduction surgery and hyperthermic intraperitoneal chemotherapy for treating advanced peritoneal metastases of hepatocellular carcinoma. Pleura Peritoneum 2020;5:20190030. [PMID: 32566724 DOI: 10.1515/pp-2019-0030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
174 Tabrizian P, Roayaie S, Schwartz ME. Current management of hepatocellular carcinoma. World J Gastroenterol. 2014;20:10223-10237. [PMID: 25132740 DOI: 10.3748/wjg.v20.i30.10223] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
175 Park SJ, Lee DH, Han JK. Reducing Pain by Artificial Ascites Infusion During Radiofrequency Ablation for Subcapsular Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 2021;44:565-73. [PMID: 33388866 DOI: 10.1007/s00270-020-02723-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
176 Shirai K, Tamai H, Shingaki N, Mori Y, Moribata K, Enomoto S, Deguchi H, Ueda K, Maekita T, Inoue I, Iguchi M, Yanaoka K, Oka M, Ichinose M. Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma: Seeding after RFA for HCC. Hepatology Research 2011;41:738-45. [DOI: 10.1111/j.1872-034x.2011.00841.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
177 Peng ZW, Lin XJ, Zhang YJ, Liang HH, Guo RP, Shi M, Chen MS. Radiofrequency ablation vs hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology. 2012;262:1022-1033. [PMID: 22357902 DOI: 10.1148/radiol.11110817] [Cited by in Crossref: 141] [Cited by in F6Publishing: 112] [Article Influence: 15.7] [Reference Citation Analysis]
178 Chini EN, Brown MJ, Farrell MA, Charboneau JW. Hypertensive crisis in a patient undergoing percutaneous radiofrequency ablation of an adrenal mass under general anesthesia. Anesth Analg 2004;99:1867-9. [PMID: 15562089 DOI: 10.1213/01.ANE.0000136803.54212.E1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
179 Zhao WC, Yang N, Zhu N, Zhang HB, Fu Y, Zhou HB, Cai WK, Chen BD, Yang GS. Patients with multiple hepatocellular carcinomas within the UCSF criteria have outcomes after curative resection similar to patients within the BCLC early-stage criteria. World J Surg. 2012;36:1811-1823. [PMID: 22526045 DOI: 10.1007/s00268-012-1601-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
180 Majno P, Giostra E, Mentha G. Management of hepatocellular carcinoma on the waiting list before liver transplantation: Time for controlled trials? Liver Transpl 2007;13:S27-35. [DOI: 10.1002/lt.21328] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
181 Fitzmorris P, Shoreibah M, Anand BS, Singal AK. Management of hepatocellular carcinoma. J Cancer Res Clin Oncol 2015;141:861-76. [DOI: 10.1007/s00432-014-1806-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 8.4] [Reference Citation Analysis]
182 Liu B, Jiang C, Chen S, Huang G, Wang Y, Li J, Xu M, Xie X, Kuang M. Multipronged ethanol ablation combined with TACE for intermediate hepatocellular carcinoma. Minim Invasive Ther Allied Technol 2018;27:300-8. [PMID: 29390939 DOI: 10.1080/13645706.2018.1427598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
183 European Association For The Study Of The Liver. European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908-943. [PMID: 22424438 DOI: 10.1016/j.jhep.2011.12.001] [Cited by in Crossref: 3642] [Cited by in F6Publishing: 3340] [Article Influence: 404.7] [Reference Citation Analysis]
184 Gandini A, Melodelima D, Schenone F, N’Djin AW, Chapelon JY, Rivoire M. High-intensity focused ultrasound (HIFU)-assisted hepatic resection in an animal model. Ann Surg Oncol. 2012;19 Suppl 3:S447-S454. [PMID: 21796492 DOI: 10.1245/s10434-011-1875-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
185 Cha DI, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, Sinn DH, Kim K. Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure. Eur Radiol 2019;29:2706-15. [PMID: 30506222 DOI: 10.1007/s00330-018-5868-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
186 Goodman M, Geller DA. Radiofrequency Ablation of Hepatocellular Carcinoma. In: Carr BI, editor. Hepatocellular Cancer. Totowa: Humana Press; 2005. pp. 171-83. [DOI: 10.1007/978-1-59259-844-1_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
187 Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, Kohara K, Shigenobu S, Ishibashi K, Arima T. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97:1253-1262. [PMID: 12599233 DOI: 10.1002/cncr.11168] [Cited by in Crossref: 239] [Cited by in F6Publishing: 208] [Article Influence: 13.3] [Reference Citation Analysis]
188 Nicoli N, Casaril A, Abu Hilal M, Mangiante G, Marchiori L, Ciola M, Invernizzi L, Campagnaro T, Mansueto G. A case of rapid intrahepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. Am J Surg. 2004;188:165-167. [PMID: 15249243 DOI: 10.1016/j.amjsurg.2003.12.061] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
189 Huo T, Lee S. Management of inoperable hepatocellular carcinoma. J Gastroenterol Hepatol 2004;19:S272-8. [DOI: 10.1111/j.1440-1746.2004.03686.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
190 Wang Y, Wang W, Wang Y, Tang J. Ultrasound-guided high-intensity focused ultrasound treatment for needle-track seeding of hepatocellular carcinoma: preliminary results. Int J Hyperthermia. 2010;26:441-447. [PMID: 20433314 DOI: 10.3109/02656731003705686] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
191 [DOI: 10.1117/12.2253479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
192 Rim CH, Seong J. Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines. Radiat Oncol J. 2016;34:160-167. [PMID: 27730805 DOI: 10.3857/roj.2016.01970] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 8.6] [Reference Citation Analysis]
193 Nagae G, Ido K, Isoda N, Sato S, Kita H, Sugano K. LAPAROSCOPIC ABLATION THERAPY FOR HEPATOCELLULAR CARCINOMA. Dig Endosc 2005;17:1-8. [DOI: 10.1111/j.1443-1661.2005.00471.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
194 Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg. 2003;237:171-179. [PMID: 12560774 DOI: 10.1097/00000658-200302000-00005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
195 Wong J, Lee KF, Yu SC, Lee PS, Cheung YS, Chong CN, Ip PC, Lai PB. Percutaneous radiofrequency ablation versus surgical radiofrequency ablation for malignant liver tumours: the long-term results. HPB (Oxford) 2013;15:595-601. [PMID: 23458320 DOI: 10.1111/hpb.12014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
196 Davis CR. Interventional radiological treatment of hepatocellular carcinoma. Cancer Control 2010;17:87-99. [PMID: 20404792 DOI: 10.1177/107327481001700204] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
197 Chen X, Zhuang J, Kolb JF, Schoenbach KH, Beebe SJ. Long term survival of mice with hepatocellular carcinoma after pulse power ablation with nanosecond pulsed electric fields. Technol Cancer Res Treat. 2012;11:83-93. [PMID: 22181334 DOI: 10.7785/tcrt.2012.500237] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
198 Chan J, Perini M, Fink M, Nikfarjam M. The outcomes of central hepatectomy versus extended hepatectomy: a systematic review and meta-analysis. HPB (Oxford) 2018;20:487-96. [PMID: 29439847 DOI: 10.1016/j.hpb.2017.12.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
199 Kang TW, Lim HK, Lee MW, Kim YS, Rhim H, Lee WJ, Paik YH, Kim MJ, Ahn JH. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study. Radiology. 2016;280:300-312. [PMID: 26824711 DOI: 10.1148/radiol.2016151243] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 9.2] [Reference Citation Analysis]
200 Poon RT. Liver Transplantation for Solitary Hepatocellular Carcinoma Less than 3 cm in Diameter in Child A Cirrhosis. Dig Dis 2007;25:334-40. [DOI: 10.1159/000106914] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
201 Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, Yoshikawa M, Kondo F, Saisho H. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol. 2005;43:458-464. [PMID: 16005538 DOI: 10.1016/j.jhep.2005.03.033] [Cited by in Crossref: 129] [Cited by in F6Publishing: 106] [Article Influence: 8.1] [Reference Citation Analysis]
202 Lencioni R, Crocetti L. A Critical Appraisal of the Literature on Local Ablative Therapies for Hepatocellular Carcinoma. Clinics in Liver Disease 2005;9:301-14. [DOI: 10.1016/j.cld.2004.12.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
203 Zarrinpar A, Kaldas F, Busuttil RW. Liver transplantation for hepatocellular carcinoma: an update. Hepatobiliary & Pancreatic Diseases International 2011;10:234-42. [DOI: 10.1016/s1499-3872(11)60039-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
204 Laeseke PF, Sampson LA, Brace CL, Winter TC, Fine JP, Lee FT. Unintended thermal injuries from radiofrequency ablation: protection with 5% dextrose in water. AJR Am J Roentgenol. 2006;186:S249-S254. [PMID: 16632684 DOI: 10.2214/ajr.04.1240] [Cited by in Crossref: 65] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
205 Takatsuki M, Soyama A, Muraoka I, Hara T, Kinoshita A, Yamaguchi I, Tanaka T, Kuroki T, Eguchi S. Post-operative complications requiring hospitalization more than one yr after living donor liver transplantation. Clin Transplant 2014;28:105-10. [DOI: 10.1111/ctr.12287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
206 Cao W, Li JH, Feng DY, Wan Y, Liu YF, Yang QF, Cheng JW, Zhao SY, Zhang HX. Effect of transarterial pulsed perfusion with heated saline on tumor vascular permeability in a rabbit VX2 liver tumor model. Eur J Radiol 2012;81:e209-16. [PMID: 21345630 DOI: 10.1016/j.ejrad.2011.01.108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
207 Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg. 2003;237:171-179. [PMID: 12560774 DOI: 10.1097/01.sla.0000048443.71734.bf] [Cited by in Crossref: 127] [Cited by in F6Publishing: 78] [Article Influence: 7.1] [Reference Citation Analysis]
208 Buscarini E, Buscarini L. Radiofrequency thermal ablation with expandable needle of focal liver malignancies: complication report. Eur Radiol. 2004;14:31-37. [PMID: 14564470 DOI: 10.1007/s00330-003-1990-9] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 3.6] [Reference Citation Analysis]
209 Kim YJ, Raman SS, Yu NC, Busuttil RW, Tong M, Lu DS. Radiofrequency ablation of hepatocellular carcinoma: can subcapsular tumors be safely ablated? AJR Am J Roentgenol. 2008;190:1029-1034. [PMID: 18356451 DOI: 10.2214/ajr.07.2293] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
210 Sugo H, Ishizaki Y, Yoshimoto J, Imamura H, Kawasaki S. Salvage hepatectomy for local recurrent hepatocellular carcinoma after ablation therapy. Ann Surg Oncol. 2012;19:2238-2245. [PMID: 22302262 DOI: 10.1245/s10434-012-2220-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
211 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol. 2010;2:417-424. [PMID: 21179308 DOI: 10.4329/wjr.v2.ill.417] [Reference Citation Analysis]
212 Ahmed M, Goldberg SN. Thermal ablation therapy for hepatocellular carcinoma. J Vasc Interv Radiol 2002;13:S231-44. [PMID: 12354841 DOI: 10.1016/s1051-0443(07)61791-6] [Cited by in Crossref: 69] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
213 Crocetti L, Lencioni R. Thermal ablation of hepatocellular carcinoma. Cancer Imaging 2008;8:19-26. [PMID: 18331969 DOI: 10.1102/1470-7330.2008.0004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
214 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol. 2010;2:417-424. [PMID: 21179308 DOI: 10.4329/wjr.v2.i11.417] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 55] [Article Influence: 6.0] [Reference Citation Analysis]
215 Cucchetti A, Piscaglia F, Cescon M, Ercolani G, Pinna AD. Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol. 2013;19:4106-4118. [PMID: 23864773 DOI: 10.3748/wjg.v19.i26.4106] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
216 Latteri F, Sandonato L, Di Marco V, Parisi P, Cabibbo G, Lombardo G, Galia M, Midiri M, Latteri MA, Craxì A. Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. Dig Liver Dis. 2008;40:684-689. [PMID: 18294940 DOI: 10.1016/j.dld.2007.12.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
217 Zhong-yi Z, Wei Y, Kun Y, Ying D, Wei W, Jung-chieh L, Min-hua C. Needle track seeding after percutaneous radiofrequency ablation of hepatocellular carcinoma: 14-year experience at a single centre. International Journal of Hyperthermia 2016;33:454-8. [DOI: 10.1080/02656736.2017.1278630] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
218 Stigliano R, Burroughs A. Should we biopsy each liver mass suspicious for HCC before liver transplantation?–No, please don't. Journal of Hepatology 2005;43:563-8. [DOI: 10.1016/j.jhep.2005.07.015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
219 Birth M, Hildebrand P, Dahmen G, Ziegler A, Br�ring DC, Hillert C, Bruch HP. Aktueller Stand der Radiofrequenzablation von Lebertumoren. Der Chirurg 2004;75:417-23. [DOI: 10.1007/s00104-003-0801-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
220 Abrams P, Marsh JW. Current approach to hepatocellular carcinoma. Surg Clin North Am. 2010;90:803-816. [PMID: 20637949 DOI: 10.1016/j.suc.2010.04.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
221 Zhou Y, Yang Y, Zhou B, Wang Z, Zhu R, Chen X, Ouyang J, Li Q, Zhou J. Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria. J Hepatocell Carcinoma 2021;8:625-44. [PMID: 34189133 DOI: 10.2147/JHC.S298709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
222 Wong J, Lee K, Lee P, Ho S, Yu S, Ng W, Cheung Y, Tsang Y, Ling E, Lai P. Radiofrequency Ablation for 110 Malignant Liver Tumours: Preliminary Results on Percutaneous and Surgical Approaches. Asian Journal of Surgery 2009;32:13-20. [DOI: 10.1016/s1015-9584(09)60003-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
223 Sherman M, Takayama Y. Screening and treatment for hepatocellular carcinoma. Gastroenterology Clinics of North America 2004;33:671-91. [DOI: 10.1016/j.gtc.2004.04.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
224 Jamil M, Ng E. Quantification of the effect of electrical and thermal parameters on radiofrequency ablation for concentric tumour model of different sizes. Journal of Thermal Biology 2015;51:23-32. [DOI: 10.1016/j.jtherbio.2015.03.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
225 Nakachi K, Tamai H, Mori Y, Shingaki N, Moribata K, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M. Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography. Cancer Imaging. 2014;14:7. [PMID: 25608454 DOI: 10.1186/1470-7330-14-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
226 Livraghi T. Radiofrequency ablation of hepatocellular carcinoma. Surg Oncol Clin N Am. 2011;20:281-299, viii. [PMID: 21377584 DOI: 10.1016/j.soc.2010.11.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
227 Miraglia R, Pietrosi G, Maruzzelli L, Petridis I, Caruso S, Marrone G, Mamone G, Vizzini G, Luca A, Gridelli B. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma. World J Gastroenterol 2007;13:2952-5. [PMID: 17589945 DOI: 10.3748/wjg.v13.i21.2952] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
228 Chen L, Sun J, Yang X. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status. Cancer Lett. 2016;370:78-84. [PMID: 26472630 DOI: 10.1016/j.canlet.2015.09.020] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
229 Nagarajan VK, Gogineni VR, White SB, Yu B. Real time evaluation of tissue optical properties during thermal ablation of ex vivo liver tissues. Int J Hyperthermia 2019;35:176-82. [PMID: 30130988 DOI: 10.1080/02656736.2018.1488278] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
230 Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;252:903-912. [PMID: 21107100 DOI: 10.1097/sla.0b013e3181efc656] [Cited by in Crossref: 469] [Cited by in F6Publishing: 199] [Article Influence: 42.6] [Reference Citation Analysis]
231 Yin Z, Jin H, Ma T, Zhou Y, Yu M, Jian Z. A meta-analysis of long-term survival outcomes between surgical resection and radiofrequency ablation in patients with single hepatocellular carcinoma ≤ 2 cm (BCLC very early stage). Int J Surg 2018;56:61-7. [PMID: 29723677 DOI: 10.1016/j.ijsu.2018.04.048] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
232 Chen QF, Huang T, Si-Tu QJ, Wu P, Shen L, Li W, Huang Z. Analysis of competing endogenous RNA network identifies a poorly differentiated cancer-specific RNA signature for hepatocellular carcinoma. J Cell Biochem 2020;121:2303-17. [PMID: 31642123 DOI: 10.1002/jcb.29454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
233 Yang WL, Nair DG, Makizumi R, Gallos G, Ye X, Sharma RR, Ravikumar TS. Heat shock protein 70 is induced in mouse human colon tumor xenografts after sublethal radiofrequency ablation. Ann Surg Oncol 2004;11:399-406. [PMID: 15070600 DOI: 10.1245/ASO.2004.08.013] [Cited by in Crossref: 41] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
234 Imai K, Beppu T, Nakayama Y, Ishiko T, Horino K, Komori H, Masuda T, Hayashi H, Okabe H, Baba Y, Watanabe M, Takamori H, Awai K, Yamashita Y, Baba H. Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy. J Surg Oncol 2009;100:121-6. [PMID: 19402077 DOI: 10.1002/jso.21302] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
235 Giorgio A, Tarantino L, de Stefano G, Scala V, Liorre G, Scarano F, Perrotta A, Farella N, Aloisio V, Mariniello N, Coppola C, Francica G, Ferraioli G. Percutaneous Sonographically Guided Saline-Enhanced Radiofrequency Ablation of Hepatocellular Carcinoma. American Journal of Roentgenology 2003;181:479-84. [DOI: 10.2214/ajr.181.2.1810479] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 2.7] [Reference Citation Analysis]
236 Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, Caralt T, Ayuso JR, Solé M, Sanchez M. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology. 2003;38:1034-1042. [PMID: 14512891 DOI: 10.1002/hep.1840380430] [Cited by in Crossref: 297] [Cited by in F6Publishing: 155] [Article Influence: 16.5] [Reference Citation Analysis]
237 Worakitsitisatorn A, Lu DS, Lee MW, Asvadi NH, Moshksar A, Yuen AD, McWilliams J, Raman SS. Percutaneous thermal ablation of subcapsular hepatocellular carcinomas: influence of tumor-surface contact and protrusion on therapeutic efficacy and safety. Eur Radiol 2020;30:1813-21. [PMID: 31822975 DOI: 10.1007/s00330-019-06497-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
238 Molinari M, Helton S. Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: a Markov model decision analysis. Am J Surg. 2009;198:396-406. [PMID: 19520354 DOI: 10.1016/j.amjsurg.2009.01.016] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
239 Takayasu K, Arii S, Sakamoto M, Matsuyama Y, Kudo M, Ichida T, Nakashima O, Matsui O, Izumi N, Ku Y. Clinical implication of hypovascular hepatocellular carcinoma studied in 4,474 patients with solitary tumour equal or less than 3 cm. Liver Int. 2013;33:762-770. [PMID: 23445409 DOI: 10.1111/liv.12130] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
240 Delis S, Bramis I, Triantopoulou C, Madariaga J, Dervenis C. The imprint of radiofrequency in the management of hepatocellular carcinoma. HPB (Oxford) 2006;8:255-63. [PMID: 18333136 DOI: 10.1080/13651820500273673] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
241 Rogger TM, Michielan A, Sferrazza S, Pravadelli C, Moser L, Agugiaro F, Vettori G, Seligmann S, Merola E, Maida M, Ciarleglio FA, Brolese A, de Pretis G. Gastrointestinal tract injuries after thermal ablative therapies for hepatocellular carcinoma: A case report and review of the literature. World J Gastroenterol 2020;26:5375-86. [PMID: 32994695 DOI: 10.3748/wjg.v26.i35.5375] [Reference Citation Analysis]
242 Dai WC, Cheung TT. Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence. Expert Rev Anticancer Ther 2016;16:1063-72. [PMID: 27548586 DOI: 10.1080/14737140.2016.1226136] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
243 Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228:235-240. [PMID: 12759473 DOI: 10.1148/radiol.2281020718] [Cited by in Crossref: 701] [Cited by in F6Publishing: 578] [Article Influence: 38.9] [Reference Citation Analysis]
244 López Ortega S, González Grande R, Santaella Leiva I, De la Cruz Lombardo J, Jiménez Pérez M. Chest Wall Implantation Metastasis Caused by Percutaneous Interventional Procedure Appearing 12 Years After Liver Transplantation: A Case Report. Transplant Proc 2020;52:587-8. [PMID: 32037069 DOI: 10.1016/j.transproceed.2019.11.038] [Reference Citation Analysis]
245 Kitada T, Murakami T, Kuzushita N, Minamitani K, Nakajo K, Osuga K, Miyoshi E, Nakamura H, Kishino B, Tamura S, Hayashi N. Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas. Hepatol Res 2008;38:565-71. [PMID: 18218008 DOI: 10.1111/j.1872-034X.2007.00308.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
246 Tranberg KG. Percutaneous ablation of liver tumours. Best Pract Res Clin Gastroenterol. 2004;18:125-145. [PMID: 15123088 DOI: 10.1016/j.bpg.2003.08.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
247 Hinoshita E, Taguchi K, Inokuchi A, Uchiumi T, Kinukawa N, Shimada M, Tsuneyoshi M, Sugimachi K, Kuwano M. Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. J Hepatol. 2001;35:765-773. [PMID: 11738104 DOI: 10.1007/s11605-011-1484-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
248 Patel PA, Ingram L, Wilson ID, Breen DJ. No-touch Wedge Ablation Technique of Microwave Ablation for the Treatment of Subcapsular Tumors in the Liver. Journal of Vascular and Interventional Radiology 2013;24:1257-62. [DOI: 10.1016/j.jvir.2013.04.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
249 Lencioni R, Cioni D, Crocetti L, Bartolozzi C. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art. Liver Transpl 2004;10:S91-7. [PMID: 14762847 DOI: 10.1002/lt.20043] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
250 Yamakado K, Akeboshi M, Nakatsuka A, Takaki H, Takao M, Kobayashi H, Taguchi O, Takeda K. Tumor seeding following lung radiofrequency ablation: a case report. Cardiovasc Intervent Radiol 2005;28:530-2. [PMID: 15983857 DOI: 10.1007/s00270-004-0246-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
251 Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, Okazaki M, Okita K, Omata M, Kudo M, Kojiro M, Nakanuma Y, Takayasu K, Monden M, Matsuyama Y, Ikai I. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol. 2008;49:589-594. [PMID: 18620773 DOI: 10.1016/j.jhep.2008.05.018] [Cited by in Crossref: 124] [Cited by in F6Publishing: 116] [Article Influence: 9.5] [Reference Citation Analysis]
252 Kuang M, Lu MD, Xie XY, Xu HX, Xu ZF, Liu GJ, Yin XY, Huang JF, Lencioni R. Ethanol ablation of hepatocellular carcinoma Up to 5.0 cm by using a multipronged injection needle with high-dose strategy. Radiology. 2009;253:552-561. [PMID: 19709992 DOI: 10.1148/radiol.2532082021] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
253 Abdalla EK, Vauthey J. Technique and Patient Selection, Not the Needle, Determine Outcome of Percutaneous Intervention for Hepatocellular Carcinoma. Ann Surg Oncol 2004;11:240-1. [DOI: 10.1245/aso.2004.01.924] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
254 Kong WT, Zhang WW, Qiu YD, Zhou T, Qiu JL, Zhang W, Ding YT. Major complications after radiofrequency ablation for liver tumors: analysis of 255 patients. World J Gastroenterol 2009;15:2651-6. [PMID: 19496197 DOI: 10.3748/wjg.15.2651] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 57] [Article Influence: 5.2] [Reference Citation Analysis]
255 Elliott BA, Curry TB, Atwell TD, Brown MJ, Rose SH. Lung Isolation, One-Lung Ventilation, and Continuous Positive Airway Pressure with Air for Radiofrequency Ablation of Neoplastic Pulmonary Lesions. Anesthesia & Analgesia 2006;103:463-4. [DOI: 10.1213/01.ane.0000223672.30521.d8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
256 Shiina S. Image-guided percutaneous ablation therapies for hepatocellular carcinoma. J Gastroenterol 2009;44:122-31. [DOI: 10.1007/s00535-008-2263-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
257 Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology. 2012;262:43-58. [PMID: 22190656 DOI: 10.1148/radiol.11110144] [Cited by in Crossref: 211] [Cited by in F6Publishing: 194] [Article Influence: 23.4] [Reference Citation Analysis]
258 Senent SG, Raposo CG, Marcos NM, Chavarri SM, Alonso GC, Martín AO, Cabral JMS, Barón MG. Radiofrequency ablation for hepatocellular carcinoma and liver metastases: Experience in Hospital La Paz. Clin Transl Oncol 2006;8:688-91. [DOI: 10.1007/s12094-006-0040-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
259 Kawamura Y, Ikeda K, Shindoh J, Kobayashi Y, Kasuya K, Fujiyama S, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Arase Y, Hashimoto M, Kumada H. No-touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection: No-touch ablation for HCC. Hepatol Res 2019;49:164-76. [DOI: 10.1111/hepr.13254] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
260 Stone MJ, Fulmer JM, Klintmalm GB. Transplantation for Primary Hepatic Malignancy. Transplantation of the Liver. Elsevier; 2005. pp. 211-31. [DOI: 10.1016/b978-0-7216-0118-2.50020-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
261 Decadt B, Siriwardena AK. Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol. 2004;5:550-560. [PMID: 15337485 DOI: 10.1016/s1470-2045(04)01567-0] [Cited by in Crossref: 135] [Cited by in F6Publishing: 30] [Article Influence: 7.9] [Reference Citation Analysis]
262 Trumm CG, Hoffmann R. CT-Guided Biopsy and Drainage. In: Reiser MF, Becker C, Nikolaou K, Glazer G, editors. Multislice CT. Berlin: Springer Berlin Heidelberg; 2009. pp. 511-34. [DOI: 10.1007/978-3-540-33125-4_37] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
263 Liem MS, Poon RT, Lo CM, Tso WK, Fan ST. Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation. World J Gastroenterol. 2005;11:4465-4471. [PMID: 16052673 DOI: 10.3748/wjg.v11.i29.4465] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
264 Francica G. Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge. J Hepatocell Carcinoma 2017;4:23-7. [PMID: 28176952 DOI: 10.2147/JHC.S106558] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
265 Gwyther S. New imaging techniques in cancer management. Annals of Oncology 2005;16:ii63-70. [DOI: 10.1093/annonc/mdi727] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
266 Lencioni R, Crocetti L, Pina MCD, Cioni D. Percutaneous image-guided radiofrequency ablation of liver tumors. Abdom Imaging 2009;34:547-56. [DOI: 10.1007/s00261-008-9479-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
267 Bolondi L, Gaiani S, Celli N, Piscaglia F. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001;34:608; author reply 610-1. [PMID: 11526551 DOI: 10.1002/hep.510340325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 0.1] [Reference Citation Analysis]
268 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: a literature review. Int J Hepatol. 2011;2011:104685. [PMID: 21994847 DOI: 10.4061/2011/104685] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 5.4] [Reference Citation Analysis]
269 Lin LW, Lin XY, He YM, Gao SD, Xue ES, Lin XD, Yu LY. Experimental and clinical assessment of percutaneous hepatic quantified ethanol injection in treatment of hepatic carcinoma. World J Gastroenterol 2004;10:3112-7. [PMID: 15457554 DOI: 10.3748/wjg.v10.i21.3112] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
270 Singh R, Torti SV. Carbon nanotubes in hyperthermia therapy. Adv Drug Deliv Rev 2013;65:2045-60. [PMID: 23933617 DOI: 10.1016/j.addr.2013.08.001] [Cited by in Crossref: 142] [Cited by in F6Publishing: 106] [Article Influence: 17.8] [Reference Citation Analysis]
271 Gervais DA, Arellano RS. Percutaneous tumor ablation for hepatocellular carcinoma. AJR Am J Roentgenol. 2011;197:789-794. [PMID: 21940565 DOI: 10.2214/ajr.11.7656] [Cited by in Crossref: 46] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
272 Moribata K, Tamai H, Shingaki N, Mori Y, Enomoto S, Shiraki T, Deguchi H, Ueda K, Inoue I, Maekita T. Assessment of malignant potential of small hypervascular hepatocellular carcinoma using B-mode ultrasonography. Hepatol Res. 2011;41:233-239. [PMID: 21272166 DOI: 10.1111/j.1872-034X.2010.00763.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
273 Wei F, Huang Q, Zhou Y, Luo L, Zeng Y. Radiofrequency ablation versus repeat hepatectomy in the treatment of recurrent hepatocellular carcinoma in subcapsular location: a retrospective cohort study. World J Surg Oncol 2021;19:175. [PMID: 34127007 DOI: 10.1186/s12957-021-02277-4] [Reference Citation Analysis]
274 Rougier P, Mitry E, Barbare JC, Taieb J. Hepatocellular carcinoma (HCC): an update. Semin Oncol. 2007;34:S12-S20. [PMID: 17449346 DOI: 10.1053/j.seminoncol.2007.01.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
275 Wu L, Chen C, Liu C, Chen M, Liu P, Liu P, Seror O, Lee I, Lin S. Multipolar radiofrequency ablation with non-touch technique for hepatocellular carcinoma ≤ 3 cm: A preliminary report. Advances in Digestive Medicine 2014;1:80-5. [DOI: 10.1016/j.aidm.2013.09.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
276 Gores G. Hepatocellular carcinoma: Gardening strategies and bridges to transplantation. Liver Transplantation 2003;9:199-200. [DOI: 10.1053/jlts.2003.0090199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
277 Takami Y, Ryu T, Wada Y, Saitsu H. Evaluation of intraoperative microwave coagulo-necrotic therapy (MCN) for hepatocellular carcinoma: a single center experience of 719 consecutive cases. J Hepatobiliary Pancreat Sci 2013;20:332-41. [PMID: 22710886 DOI: 10.1007/s00534-012-0527-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
278 Petit A, Hocquelet A, N'kontchou G, Varin E, Sellier N, Seror O, Sutter O. No-Touch Multi-bipolar Radiofrequency Ablation for the Treatment of Subcapsular Hepatocellular Carcinoma ≤ 5 cm Not Puncturable via the Non-tumorous Liver Parenchyma. Cardiovasc Intervent Radiol 2020;43:273-83. [PMID: 31673728 DOI: 10.1007/s00270-019-02357-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
279 Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, Dela Torre A, Cho KC, Contractor D, Korogodsky M. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. Journal of the American College of Surgeons 2003;197:759-64. [DOI: 10.1016/s1072-7515(03)00750-6] [Cited by in Crossref: 95] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
280 Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004;10:S115-S120. [PMID: 14762851 DOI: 10.1002/lt.20034] [Cited by in Crossref: 459] [Cited by in F6Publishing: 409] [Article Influence: 27.0] [Reference Citation Analysis]
281 Mendizabal M, Reddy KR. Current Management of Hepatocellular Carcinoma. Medical Clinics of North America 2009;93:885-900. [DOI: 10.1016/j.mcna.2009.03.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
282 Nakagomi R, Tateishi R, Shiina S, Imamura J, Fujiwara N, Asaoka Y, Kondo Y, Koike K. Drastically Reduced Neoplastic Seeding Related to Radiofrequency Ablation for Hepatocellular Carcinoma. American Journal of Gastroenterology 2014;109:774-6. [DOI: 10.1038/ajg.2014.42] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
283 Karaosmanoglu AD, Onur MR, Ozmen MN, Akata D, Karcaaltincaba M. Magnetic Resonance Imaging of Liver Metastasis. Semin Ultrasound CT MR. 2016;37:533-548. [PMID: 27986172 DOI: 10.1053/j.sult.2016.08.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
284 Burke AR, Singh RN, Carroll DL, Wood JC, D'Agostino RB Jr, Ajayan PM, Torti FM, Torti SV. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials 2012;33:2961-70. [PMID: 22245557 DOI: 10.1016/j.biomaterials.2011.12.052] [Cited by in Crossref: 129] [Cited by in F6Publishing: 108] [Article Influence: 14.3] [Reference Citation Analysis]
285 Yu HC, Cheng JS, Lai KH, Lin CP, Lo GH, Lin CK, Hsu PI, Chan HH, Lo CC, Tsai WL, Chen WC. Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J Gastroenterol 2005;11:1439-44. [PMID: 15770718 DOI: 10.3748/wjg.v11.i10.1439] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
286 Reddy CV, Goud YG, Poornima R, Deshmane V, Madhusudhana BA, Gayathridevi M. Role of FNAC in Hepatic lesions: Risk of track metastases. South Asian J Cancer 2015;4:35-7. [PMID: 25839019 DOI: 10.4103/2278-330X.149949] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
287 Salmi A, Turrini R, Lanzani G, Savio A, Anglani L. Efficacy of radiofrequency ablation of hepatocellular carcinoma associated with chronic liver disease without cirrhosis. Int J Med Sci 2008;5:327-32. [PMID: 18974861 DOI: 10.7150/ijms.5.327] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
288 Alsowmely AM, Hodgson HJ. Non-surgical treatment of hepatocellular carcinoma. Aliment Pharmacol Ther. 2002;16:1-15. [PMID: 11856073 DOI: 10.1046/j.1365-2036.2002.01149.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
289 Hai S, Okada T, Iimuro Y, Hirano T, Suzumura K, Fujimoto J. Successful laparoscopic extirpation of peritoneal dissemination after hepatectomy for ruptured hepatocellular carcinoma. Asian J Endosc Surg 2015;8:465-7. [PMID: 26708587 DOI: 10.1111/ases.12212] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
290 Howenstein MJ, Sato KT. Complications of radiofrequency ablation of hepatic, pulmonary, and renal neoplasms. Semin Intervent Radiol. 2010;27:285-295. [PMID: 22550368 DOI: 10.1055/s-0030-1261787] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
291 Strasberg SM, Linehan D. Radiofrequency ablation of liver tumors. Curr Probl Surg. 2003;40:459-498. [PMID: 12865889 DOI: 10.1016/s0011-3840(03)00050-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
292 Mulier S, Ni Y, Jamart J, Michel L, Marchal G, Ruers T. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol. 2008;15:144-157. [PMID: 17906898 DOI: 10.1245/s10434-007-9478-5] [Cited by in Crossref: 98] [Cited by in F6Publishing: 77] [Article Influence: 7.0] [Reference Citation Analysis]
293 Enomoto S, Tamai H, Shingaki N, Mori Y, Moribata K, Shiraki T, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Yanaoka K, Oka M, Ichinose M. Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis. Hepatol Int 2011;5:730-7. [PMID: 21484138 DOI: 10.1007/s12072-010-9245-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
294 Lopez KT, Kuwada SK, Wong LL. Consequences of needle tract seeding of hepatocellular cancer after liver transplant. Clin Transplant. 2013;27:E400-E406. [PMID: 23837571 DOI: 10.1111/ctr.12160] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
295 Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, Tso WK, Fan ST, Poon RT. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors. Ann Surg Oncol. 2008;15:782-790. [PMID: 18095030 DOI: 10.1245/s10434-007-9733-9] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
296 Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg. 2003;238:703-710. [PMID: 14578733 DOI: 10.1097/01.sla.0000094549.11754.e6] [Cited by in Crossref: 311] [Cited by in F6Publishing: 287] [Article Influence: 17.3] [Reference Citation Analysis]
297 Wang Q, Huang J, Ma K, Li T, Chen M, Wang S, Bie P, He Z. Evaluation of ghost cell survival in the area of radiofrequency ablation. PLoS One 2012;7:e53158. [PMID: 23300883 DOI: 10.1371/journal.pone.0053158] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
298 Ma J, Wang F, Zhang W, Wang L, Yang X, Qian Y, Huang J, Wang J, Yang J. Percutaneous cryoablation for the treatment of liver cancer at special sites: an assessment of efficacy and safety. Quant Imaging Med Surg. 2019;9:1948-1957. [PMID: 31929967 DOI: 10.21037/qims.2019.11.12] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
299 Lencioni R, Crocetti L. Image-guided thermal ablation of hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2008;66:200-7. [DOI: 10.1016/j.critrevonc.2008.01.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
300 Shen A, Zhang H, Tang C, Chen Y, Wang Y, Zhang C, Wu Z. Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm. J Gastroenterol Hepatol. 2013;28:793-800. [PMID: 23432154 DOI: 10.1111/jgh.12162] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
301 Raziff HHA, Tan D, Tan SH, Wong YH, Lim KS, Yeong CH, Sulaiman N, Abdullah BJJ, Wali HAM, Zailan NAM, Ahmad H. Laser-heated needle for biopsy tract ablation: In vivo study of rabbit liver biopsy. Phys Med 2021;82:40-5. [PMID: 33581616 DOI: 10.1016/j.ejmp.2021.01.067] [Reference Citation Analysis]
302 Llovet JM, Sala M. Non-surgical therapies of hepatocellular carcinoma: . European Journal of Gastroenterology & Hepatology 2005;17:505-13. [DOI: 10.1097/00042737-200505000-00006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
303 Shibata T, Shibata T, Maetani Y, Kubo T, Nishida N, Itoh K. Transcatheter arterial embolization for tumor seeding in the chest wall after radiofrequency ablation for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2006;29:479-481. [PMID: 16160756 DOI: 10.1007/s00270-004-0107-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
304 Zanotti-Fregonara P, Hindié E, Albertini AF, Ech-Charraq I, Weinmann P, Devaux JY. (18)F-FDG PET/CT visualisation of tumor seeding after percutaneous radiofrequency ablation of metastases. Eur J Nucl Med Mol Imaging 2007;34:305. [PMID: 17048036 DOI: 10.1007/s00259-006-0241-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
305 Hansen PD, Cassera MA, Wolf RF. Ablative technologies for hepatocellular, cholangiocarcinoma, and metastatic colorectal cancer of the liver. Surg Oncol Clin N Am 2015;24:97-119. [PMID: 25444471 DOI: 10.1016/j.soc.2014.09.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
306 Damm R, Zörkler I, Rogits B, Hass P, Omari J, Powerski M, Kropf S, Mohnike K, Pech M, Ricke J, Seidensticker M. Needle track seeding in hepatocellular carcinoma after local ablation by high-dose-rate brachytherapy: a retrospective study of 588 catheter placements. J Contemp Brachytherapy 2018;10:516-21. [PMID: 30662474 DOI: 10.5114/jcb.2018.80626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
307 Marı́n-hargreaves G, Azoulay D, Bismuth H. Hepatocellular carcinoma: surgical indications and results. Critical Reviews in Oncology/Hematology 2003;47:13-27. [DOI: 10.1016/s1040-8428(02)00213-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
308 Kondo Y, Yoshida H, Shiina S, Tateishi R, Teratani T, Omata M. Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract. British Journal of Surgery 2006;93:1277-82. [DOI: 10.1002/bjs.5374] [Cited by in Crossref: 95] [Cited by in F6Publishing: 75] [Article Influence: 6.3] [Reference Citation Analysis]
309 Goldberg SN, Ahmed M. Minimally invasive image-guided therapies for hepatocellular carcinoma. J Clin Gastroenterol 2002;35:S115-29. [PMID: 12394215 DOI: 10.1097/00004836-200211002-00008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
310 Adam P, Solans-domenech M, Pons JMV, Aymerich M, Berra S, Guillamon I, Sanchez E, Permanyer-miralda G. Assessment of the impact of a clinical and health services research call in Catalonia. Research Evaluation 2012;21:319-28. [DOI: 10.1093/reseval/rvs024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
311 Wiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL, Krom RA. Recent advances in liver transplantation. Mayo Clin Proc. 2003;78:197-210. [PMID: 12583530 DOI: 10.4065/78.2.197] [Cited by in Crossref: 69] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
312 Park SY, Tak WY, Jeon SW, Cho CM, Kweon YO, Kim SK, Choi YH. The efficacy of intraperitoneal saline infusion for percutaneous radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol. 2010;74:536-540. [PMID: 19398290 DOI: 10.1016/j.ejrad.2009.03.037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
313 Fan H, Wang X, Qu J, Lu W, Xu S, Wu X, Xia J, Zhang Y, Sun J, Yang X. Comparison of Percutaneous Radiofrequency Ablation for Subcapsular and Non-Subcapsular Colorectal Cancer Liver Metastases. Front Oncol 2021;11:678490. [PMID: 34055647 DOI: 10.3389/fonc.2021.678490] [Reference Citation Analysis]
314 Abou El Azm AR, Yousef M, Mansour N, Awad A, El Dardiry S, Abdel Aziz I. New Insights on Non-B non-C Hepatocellular Carcinoma in Mid Delta Region, Egypt. J Gastrointest Canc 2014;45:276-83. [DOI: 10.1007/s12029-013-9573-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
315 Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010;52:762-73. [DOI: 10.1002/hep.23725] [Cited by in Crossref: 323] [Cited by in F6Publishing: 301] [Article Influence: 29.4] [Reference Citation Analysis]
316 Mendiratta-Lala M, Brook OR, Midkiff BD, Brennan DD, Thornton E, Faintuch S, Sheiman RG, Goldberg SN. Quality initiatives: strategies for anticipating and reducing complications and treatment failures in hepatic radiofrequency ablation. Radiographics. 2010;30:1107-1122. [PMID: 20442337 DOI: 10.1148/rg.304095202] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
317 Lopez PM, Villanueva A, Roayaie S, Llovet JM. Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal. Liver Transpl. 2006;12:1747-1754. [PMID: 17133591 DOI: 10.1002/lt.21018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
318 Tinkle CL, Haas-Kogan D. Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics 2012;6:207-19. [PMID: 22904613 DOI: 10.2147/BTT.S23907] [Cited by in Crossref: 5] [Cited by in F6Publishing: 25] [Article Influence: 0.6] [Reference Citation Analysis]
319 Santambrogio R, Opocher E, Montorsi M. Laparoscopic radiofrequency ablation of hepatocellular carcinoma: A critical review from the surgeon's perspective. J Ultrasound 2008;11:1-7. [PMID: 23396827 DOI: 10.1016/j.jus.2007.12.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
320 Morimoto M, Numata K, Nozaki A, Tanaka K. Prognosis following non-surgical second treatment in patients with recurrent hepatocellular carcinoma after percutaneous ablation therapy. Liver International 2009;29:443-8. [DOI: 10.1111/j.1478-3231.2008.01890.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
321 Ueno M, Uchiyama K, Ozawa S, Nakase T, Togo N, Hayami S, Yamaue H. Prognostic impact of treatment modalities on patients with single nodular recurrence of hepatocellular carcinoma. Surg Today 2009;39:675-81. [PMID: 19639434 DOI: 10.1007/s00595-008-3942-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
322 Hsieh Y, Limquiaco JL, Lin C, Chen W, Lin S. Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations. Abdom Radiol 2019;44:1141-51. [DOI: 10.1007/s00261-018-1831-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
323 Lermite E, Lebigot J, Oberti F, Pessaux P, Aube C, Cales P, Arnaud J. Radiofrequency thermal ablation of liver carcinoma. Gastroentérologie Clinique et Biologique 2006;30:130-5. [DOI: 10.1016/s0399-8320(06)73128-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
324 Distelmaier M, Barabasch A, Heil P, Kraemer NA, Isfort P, Keil S, Kuhl CK, Bruners P. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins. Radiology. 2017;285:1023-1031. [PMID: 28799842 DOI: 10.1148/radiol.2017161561] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 10.3] [Reference Citation Analysis]
325 Eichel L, Kim IY, Uribe C, Khonsari S, Basillote J, Steward E, Coad J, Bischof J, Rudie E, Kluge S, McDougall EM, Clayman RV. Third Prize: Comparison of radical nephrectomy, laparoscopic microwave thermotherapy, cryotherapy, and radiofrequency ablation for destruction of experimental VX-2 renal tumors in rabbits. J Endourol 2005;19:1082-7. [PMID: 16283844 DOI: 10.1089/end.2005.19.1082] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
326 Han K, Lee JT, Seong J. Treatment of non-resectable hepatocellular carcinoma: Non-resectable HCC. Journal of Gastroenterology and Hepatology 2002;17:S424-7. [DOI: 10.1046/j.1440-1746.17.s3.39.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
327 Meredith K, Haemmerich D, Qi C, Mahvi D. Hepatic resection but not radiofrequency ablation results in tumor growth and increased growth factor expression. Ann Surg. 2007;245:771-776. [PMID: 17457170 DOI: 10.1097/01.sla.0000261319.51744.59] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
328 Djokic M, Cemazar M, Popovic P, Kos B, Dezman R, Bosnjak M, Zakelj MN, Miklavcic D, Potrc S, Stabuc B, Tomazic A, Sersa G, Trotovsek B. Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study. Eur J Surg Oncol. 2018;44:651-657. [PMID: 29402556 DOI: 10.1016/j.ejso.2018.01.090] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
329 Asahina Y, Nakanishi H, Izumi N. Laparoscopic radiofrequency ablation for hepatocellular carcinoma. Dig Endosc. 2009;21:67-72. [PMID: 19691776 DOI: 10.1111/j.1443-1661.2009.00844.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
330 Helton WS, Espat NJ. Invited Commentary. RadioGraphics 2001;21:S36-9. [DOI: 10.1148/radiographics.21.suppl_1.g01oc11s36] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
331 Brunello F, Veltri A, Carucci P, Pagano E, Ciccone G, Moretto P, Sacchetto P, Gandini G, Rizzetto M. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial. Scand J Gastroenterol. 2008;43:727-735. [PMID: 18569991 DOI: 10.1080/00365520701885481] [Cited by in Crossref: 181] [Cited by in F6Publishing: 160] [Article Influence: 13.9] [Reference Citation Analysis]
332 Botsa E, Poulou LS, Koutsogiannis I, Ziakas PD, Koundouraki A, Alexopoulou E, Thanos L. CT-guided radiofrequency tumor ablation in children. Pediatr Radiol 2014;44:1421-5. [PMID: 24894971 DOI: 10.1007/s00247-014-3008-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
333 Eichler K, Zangos S, Gruber-Rouh T, Vogl TJ, Mack MG. Magnetic resonance-guided laser-induced thermotherapy in patients with oligonodular hepatocellular carcinoma: long-term results over a 15-year period. J Clin Gastroenterol. 2012;46:796-801. [PMID: 22955262 DOI: 10.1097/mcg.0b013e3182641806] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
334 Enne M, Pacheco-moreira LF, Cerqueira A, Balbi E, Pereira JL, Martinho JM. Fatal hemobilia after radiofrequency thermal ablation for hepatocellular carcinoma. Surgery 2004;135:460-1. [DOI: 10.1016/j.surg.2003.10.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
335 Koda M, Murawaki Y, Hirooka Y, Kitamoto M, Ono M, Sakaeda H, Joko K, Sato S, Tamaki K, Yamasaki T, Shibata H, Shimoe T, Matsuda T, Toshikuni N, Fujioka S, Ohmoto K, Nakamura S, Kariyama K, Aikata H, Kobayashi Y, Tsutsui A. Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients: Complications of RFA for HCC. Hepatology Research 2012;42:1058-64. [DOI: 10.1111/j.1872-034x.2012.01025.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 34] [Article Influence: 7.2] [Reference Citation Analysis]
336 Du L, Zhou J, Wang X, Sheng L, Wang G, Xie X, Xu G, Zhao L, Liao Y, Tang J. Effect of local hyperthermia induced by nanometer magnetic fluid on the rabbit VX2 liver tumor model. Progress in Natural Science 2009;19:1705-12. [DOI: 10.1016/j.pnsc.2009.06.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
337 Livraghi T. To the Editor. Hepatology 2001;34:608-9. [DOI: 10.1002/hep.510340326] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
338 Lencioni R, Della Pina C, Crocetti L, Cioni D. Percutaneous Ablation of Hepatocellular Carcinoma. In: Stroszczynski C, editor. Minimally Invasive Tumor Therapies. Berlin: Springer Berlin Heidelberg; 2006. pp. 91-105. [DOI: 10.1007/3-540-28137-1_7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
339 Kim JS, Ko Y, Kwon H, Kim M, Lee JK. Impact of Energy and Access Methods on Extrahepatic Tumor Spreading and the Ablation Zone: An Ex vivo Experiment Using a Subcapsular Tumor Model. Korean J Radiol 2019;20:580-8. [PMID: 30887740 DOI: 10.3348/kjr.2018.0564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
340 Kotoh K, Nakamuta M, Morizono S, Kohjima M, Arimura E, Fukushima M, Enjoji M, Sakai H, Nawata H. A multi-step, incremental expansion method for radio frequency ablation: optimization of the procedure to prevent increases in intra-tumor pressure and to reduce the ablation time. Liver Int. 2005;25:542-547. [PMID: 15910491 DOI: 10.1111/j.1478-3231.2005.01051.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
341 Trumm CG, Hoffmann R. Biopsy. In: Mahnken AH, Ricke J, editors. CT- and MR-Guided Interventions in Radiology. Berlin: Springer Berlin Heidelberg; 2009. pp. 91-117. [DOI: 10.1007/978-3-540-73085-9_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
342 Kim JW, Shin JH, Kim PN, Shin YM, Won HJ, Ko GY, Yoon HK. Embolization for Bleeding after Hepatic Radiofrequency Ablation. J Vasc Interv Radiol 2017;28:356-365.e2. [PMID: 28012690 DOI: 10.1016/j.jvir.2016.09.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
343 Kudo M, Kawamura Y, Hasegawa K, Tateishi R, Kariyama K, Shiina S, Toyoda H, Imai Y, Hiraoka A, Ikeda M, Izumi N, Moriguchi M, Ogasawara S, Minami Y, Ueshima K, Murakami T, Miyayama S, Nakashima O, Yano H, Sakamoto M, Hatano E, Shimada M, Kokudo N, Mochida S, Takehara T. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update. Liver Cancer 2021;10:181-223. [PMID: 34239808 DOI: 10.1159/000514174] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
344 Fowler N, Asatiani E, Cheson B. Needle tract seeding after bone marrow biopsy in non-Hodgkin lymphoma. Leukemia & Lymphoma 2009;49:156-8. [DOI: 10.1080/10428190701732846] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
345 Shao J, Bai J, Cui L, Wang J, Fu Y, Liu K, Feng S. Elastographic Evaluation of the Temporal Formation of Ethanol-Induced Hepatic Lesions: Preliminary In Vitro Results. Journal of Ultrasound in Medicine 2007;26:1191-9. [DOI: 10.7863/jum.2007.26.9.1191] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
346 Lin CH, Ho CM, Wu CH, Liang PC, Wu YM, Hu RH, Lee PH, Ho MC. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis. Surg Endosc 2020;34:5566-73. [PMID: 31993821 DOI: 10.1007/s00464-019-07357-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
347 Adler M, De Pauw F, Vereerstraeten P, Fancello A, Lerut J, Starkel P, Van Vlierberghe H, Troisi R, Donckier V, Detry O, Delwaide J, Michielsen P, Chapelle T, Pirenne J, Nevens F. Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system. Liver Transpl 2008;14:526-33. [DOI: 10.1002/lt.21399] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
348 European Association for Study of Liver. European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer. 2012;48:599-641. [PMID: 22424278 DOI: 10.1016/j.ejca.2011.12.021] [Cited by in Crossref: 273] [Cited by in F6Publishing: 255] [Article Influence: 30.3] [Reference Citation Analysis]
349 Takaki H, Yamakado K, Nakatsuka A, Fuke H, Murata K, Shiraki K, Takeda K. Radiofrequency Ablation Combined with Chemoembolization for the Treatment of Hepatocellular Carcinomas 5 cm or Smaller: Risk Factors for Local Tumor Progression. Journal of Vascular and Interventional Radiology 2007;18:856-61. [DOI: 10.1016/j.jvir.2007.04.022] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
350 Loewe C, Cejna M, Schoder M, Thurnher MM, Lammer J, Thurnher SA. Arterial embolization of unresectable hepatocellular carcinoma with use of cyanoacrylate and lipiodol. J Vasc Interv Radiol. 2002;13:61-69. [PMID: 11788696 DOI: 10.1016/s1051-0443(07)60010-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
351 Ruers T, de Jong K, Ijzermans J. Radiofrequency for the Treatment of Liver Tumours. Dig Surg 2005;22:245-53. [DOI: 10.1159/000088054] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
352 Kawamura Y, Ikeda K, Seko Y, Hosaka T, Kobayashi M, Saitoh S, Kumada H. Heterogeneous Type 4 Enhancement of Hepatocellular Carcinoma on Dynamic CT Is Associated With Tumor Recurrence After Radiofrequency Ablation. American Journal of Roentgenology 2011;197:W665-73. [DOI: 10.2214/ajr.11.6843] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
353 Hasegawa K, Aoki T, Ishizawa T, Kaneko J, Sakamoto Y, Sugawara Y, Kokudo N. Comparison of the therapeutic outcomes between surgical resection and percutaneous ablation for small hepatocellular carcinoma. Ann Surg Oncol 2014;21 Suppl 3:S348-55. [PMID: 24566865 DOI: 10.1245/s10434-014-3585-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
354 Tsuji K, Nishimori H, Sakurai Y, Mitsui S, Miyamoto N, Matsunaga T, Kang J, Maguchi H, Maekubo H. Efficacy and long-term outcome of laparoscopic microwave coagulation or radiofrequency ablation therapy for surface-type hepatocellular carcinoma. Dig Endosc 2004;16:117-21. [DOI: 10.1111/j.1443-1661.2003.00323.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
355 Iida H, Aihara T, Ikuta S, Yamanaka N. Effectiveness of impedance monitoring during radiofrequency ablation for predicting popping. World J Gastroenterol 2012;18:5870-8. [PMID: 23139602 DOI: 10.3748/wjg.v18.i41.5870] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
356 Matsukuma S, Sato K. Peritoneal seeding of hepatocellular carcinoma: clinicopathological characteristics of 17 autopsy cases. Pathol Int. 2011;61:356-362. [PMID: 21615611 DOI: 10.1111/j.1440-1827.2011.02669.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
357 Dormandy TL, Munro JG. Oxyhaemoglobin without oxygen. Nature. 1965;206:410-411. [PMID: 4284287 DOI: 10.1016/j.jceh.2014.05.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 0.7] [Reference Citation Analysis]
358 Torzilli G, Belghiti J, Makuuchi M. Differences and similarities in the approach to hepatocellular carcinoma between Eastern and Western institutions. Liver Transpl 2004;10:S1-2. [PMID: 14762830 DOI: 10.1002/lt.20032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
359 Shi Y, Zhai B. A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma. Gastrointest Tumors 2016;3:90-102. [PMID: 27904861 DOI: 10.1159/000445888] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
360 Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226:441-451. [PMID: 12563138 DOI: 10.1148/radiol.2262012198] [Cited by in Crossref: 927] [Cited by in F6Publishing: 761] [Article Influence: 51.5] [Reference Citation Analysis]
361 Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2010;33:11-17. [PMID: 19924474 DOI: 10.1007/s00270-009-9736-y] [Cited by in Crossref: 165] [Cited by in F6Publishing: 149] [Article Influence: 15.0] [Reference Citation Analysis]
362 Vogl TJ, Naguib NN, Nour-eldin NA, Rao P, Emami AH, Zangos S, Nabil M, Abdelkader A. Review on transarterial chemoembolization in hepatocellular carcinoma: Palliative, combined, neoadjuvant, bridging, and symptomatic indications. European Journal of Radiology 2009;72:505-16. [DOI: 10.1016/j.ejrad.2008.08.007] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 7.1] [Reference Citation Analysis]
363 Lin Y, Chen J, Han K, Shen W. Ablation of Liver Tumor by Injection of Hypertonic Saline. American Journal of Roentgenology 2005;184:212-9. [DOI: 10.2214/ajr.184.1.01840212] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
364 Li WH, Ma KW, Cheng M, Chui KH, Chan PT, Chu WH, Fung HS, Kowk CH, Cheung MT. Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients. ANZ J Surg 2010;80:714-21. [PMID: 21040332 DOI: 10.1111/j.1445-2197.2010.05434.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
365 Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, Covino M, Ravaioli M, Fagiuoli S, Gasbarrini G, Rapaccini GL. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl. 2005;11:1117-1126. [PMID: 16123960 DOI: 10.1002/lt.20469] [Cited by in Crossref: 136] [Cited by in F6Publishing: 125] [Article Influence: 8.5] [Reference Citation Analysis]
366 Vogl TJ, Naguib NN, Lehnert T, Nour-eldin NA. Radiofrequency, microwave and laser ablation of pulmonary neoplasms: Clinical studies and technical considerations—Review article. European Journal of Radiology 2011;77:346-57. [DOI: 10.1016/j.ejrad.2009.07.034] [Cited by in Crossref: 75] [Cited by in F6Publishing: 49] [Article Influence: 7.5] [Reference Citation Analysis]
367 Takeda A, Sanuki N, Tsurugai Y, Iwabuchi S, Matsunaga K, Ebinuma H, Imajo K, Aoki Y, Saito H, Kunieda E. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation. Cancer. 2016;122:2041-2049. [PMID: 27062278 DOI: 10.1002/cncr.30008] [Cited by in Crossref: 96] [Cited by in F6Publishing: 78] [Article Influence: 19.2] [Reference Citation Analysis]
368 Morimoto M, Numata K, Nozawa A, Kondo M, Nozaki A, Nakano M, Tanaka K. Radiofrequency ablation of the liver: extended effect of transcatheter arterial embolization with iodized oil and gelatin sponge on histopathologic changes during follow-up in a pig model. J Vasc Interv Radiol 2010;21:1716-24. [PMID: 20884228 DOI: 10.1016/j.jvir.2010.06.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
369 Llatjós M, Muns R, Tallada N. Need for biopsy in hepatocellular carcinoma. Journal of Hepatology 2002;37:874. [DOI: 10.1016/s0168-8278(02)00314-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
370 Yamashita H, Nakagawa K, Shiraishi K, Tago M, Igaki H, Nakamura N, Sasano N, Shiina S, Omata M, Ohtomo K. External beam radiotherapy to treat intra- and extra-hepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. J Gastroenterol Hepatol 2006;21:1555-60. [PMID: 16928216 DOI: 10.1111/j.1440-1746.2006.04432.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
371 Kim YS, Rhim H, Cho OK, Koh BH, Kim Y. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol. 2006;59:432-441. [PMID: 16690240 DOI: 10.1016/j.ejrad.2006.03.007] [Cited by in Crossref: 176] [Cited by in F6Publishing: 156] [Article Influence: 11.7] [Reference Citation Analysis]
372 O'brien MA, Power DG, Clover AJP, Bird B, Soden DM, Forde PF. Local tumour ablative therapies: Opportunities for maximising immune engagement and activation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014;1846:510-23. [DOI: 10.1016/j.bbcan.2014.09.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
373 Minami Y, Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver 2013;7:1-6. [PMID: 23422905 DOI: 10.5009/gnl.2013.7.1.1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
374 Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, Roberts J, Reich DJ, Schwartz ME, Mieles L, Lee FT, Florman S, Yao F, Harper A, Edwards E, Freeman R, Lake J. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States: Liver Allocation in Patients With HCC. Liver Transpl 2010;16:262-78. [DOI: 10.1002/lt.21999] [Cited by in Crossref: 293] [Cited by in F6Publishing: 234] [Article Influence: 24.4] [Reference Citation Analysis]
375 Beppu T, Nakagawa S, Nitta H, Okabe H, Kaida T, Imai K, Hayashi H, Koga Y, Kuramoto K, Hashimoto D, Yamashita YI, Chikamoto A, Ishiko T, Baba H. The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma. J Clin Transl Hepatol. 2017;5:165-168. [PMID: 28660154 DOI: 10.14218/jcth.2016.00055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
376 Rodríguez-Sanjuán JC, González F, Juanco C, Herrera LA, López-Bautista M, González-Noriega M, García-Somacarrera E, Figols J, Gómez-Fleitas M, Silván M. Radiological and pathological assessment of hepatocellular carcinoma response to radiofrequency. A study on removed liver after transplantation. World J Surg. 2008;32:1489-1494. [PMID: 18373117 DOI: 10.1007/s00268-008-9559-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
377 Imamura J, Tateishi R, Shiina S, Goto E, Sato T, Ohki T, Masuzaki R, Goto T, Yoshida H, Kanai F, Hamamura K, Obi S, Yoshida H, Omata M. Neoplastic Seeding After Radiofrequency Ablation for Hepatocellular Carcinoma. The American Journal of Gastroenterology 2008;103:3057-62. [DOI: 10.1111/j.1572-0241.2008.02153.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 5.2] [Reference Citation Analysis]
378 Hanna NN. Radiofrequency ablation of primary and metastatic hepatic malignancies. Clin Colorectal Cancer 2004;4:92-100. [PMID: 15285816 DOI: 10.3816/ccc.2004.n.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
379 Ho CK, Chapman WC, Brown DB. Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: two-year follow-up. J Vasc Interv Radiol. 2007;18:1451-1453. [PMID: 18003999 DOI: 10.1016/j.jvir.2007.07.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
380 Tarantino L, Francica G, Esposito F, Pisaniello D, Parmeggiani D, Marzullo G, Sordelli IMF, Sperlongano P. Seeding from hepatocellular carcinoma after percutaneous ablation: color Doppler ultrasound findings. Abdom Imaging 2006;31:69-77. [DOI: 10.1007/s00261-004-0064-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
381 Miyayama S, Matsui O, Nishida H, Yamamori S, Minami T, Shinmura R, Kozaka K, Notsumata K, Toya D, Tanaka N. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma fed by the cystic artery. J Vasc Interv Radiol. 2003;14:1155-1161. [PMID: 14514807 DOI: 10.1097/01.RVI.0000086534.86489.10] [Cited by in Crossref: 36] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
382 Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J, Bartolozzi C. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234:961-967. [PMID: 15665226 DOI: 10.1148/radiol.2343040350] [Cited by in Crossref: 608] [Cited by in F6Publishing: 511] [Article Influence: 38.0] [Reference Citation Analysis]
383 Llovet JM, Mas X, Aponte JJ, Fuster J, Navasa M, Christensen E, Rodés J, Bruix J. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut. 2002;50:123-128. [PMID: 11772979 DOI: 10.1136/gut.50.1.123] [Cited by in Crossref: 202] [Cited by in F6Publishing: 172] [Article Influence: 10.6] [Reference Citation Analysis]
384 Hong HP, Lee JY, Lee MY, Jung KU, Kim BI, Son BH, Shin JH, Lee SR. Early experience with laparoscopic treatment of liver tumors using a separable cluster electrode with a no-touch technique. Wideochir Inne Tech Maloinwazyjne 2021;16:76-82. [PMID: 33786119 DOI: 10.5114/wiitm.2020.95065] [Reference Citation Analysis]
385 Rhim H, Yoon KH, Lee JM, Cho Y, Cho JS, Kim SH, Lee WJ, Lim HK, Nam GJ, Han SS, Kim YH, Park CM, Kim PN, Byun JY. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics. 2003;23:123-34; discussion 134-6. [PMID: 12533647 DOI: 10.1148/rg.231025054] [Cited by in Crossref: 249] [Cited by in F6Publishing: 197] [Article Influence: 13.8] [Reference Citation Analysis]
386 Llovet JM, Vilana R, Bianchi L, Brú C. [Radiofrequency in the treatment of hepatocellular carcinoma]. Gastroenterol Hepatol 2001;24:303-11. [PMID: 11459568 DOI: 10.1016/s0210-5705(01)70180-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
387 Li L, Guo X, Peng X, Zhang H, Liu Y, Li H, He X, Shi D, Xiong B, Zhao Y, Zheng C, Yang X. Radiofrequency-responsive dual-valent gold nanoclusters for enhancing synergistic therapy of tumor ablation and artery embolization. Nano Today 2020;35:100934. [DOI: 10.1016/j.nantod.2020.100934] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
388 Yamakado K, Nakatsuka A, Ohmori S, Shiraki K, Nakano T, Ikoma J, Adachi Y, Takeda K. Radiofrequency Ablation Combined with Chemoembolization in Hepatocellular Carcinoma: Treatment Response Based on Tumor Size and Morphology. Journal of Vascular and Interventional Radiology 2002;13:1225-32. [DOI: 10.1016/s1051-0443(07)61969-1] [Cited by in Crossref: 153] [Cited by in F6Publishing: 38] [Article Influence: 8.1] [Reference Citation Analysis]
389 Koda M, Ueki M, Maeda N, Murawaki Y. Diaphragmatic perforation and hernia after hepatic radiofrequency ablation. AJR Am J Roentgenol. 2003;180:1561-1562. [PMID: 12760919 DOI: 10.2214/ajr.180.6.1801561] [Cited by in Crossref: 71] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
390 Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Yoshida H, Kawabe T, Omata M. Percutaneous radiofrequency ablation for hepatocellular carcinoma: An analysis of 1000 cases. Cancer 2005;103:1201-9. [DOI: 10.1002/cncr.20892] [Cited by in Crossref: 553] [Cited by in F6Publishing: 487] [Article Influence: 34.6] [Reference Citation Analysis]
391 Hu XY, Li L, Wu HT, Liu Y, Wang BD, Tang Y. Serum miR-130b level, an ideal marker for monitoring the recurrence and prognosis of primary hepatocellular carcinoma after radiofrequency ablation treatment. Pathol Res Pract 2018;214:1655-60. [PMID: 30153957 DOI: 10.1016/j.prp.2018.08.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
392 Izumi N. Recent advances of radiofrequency ablation for early hepatocellular carcinoma. J Gastroenterol Hepatol. 2011;26 Suppl 1:115-122. [PMID: 21199522 DOI: 10.1111/j.1440-1746.2010.06543.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
393 Hinshaw J, Lee FT. Image-guided ablation of renal cell carcinoma. Magnetic Resonance Imaging Clinics of North America 2004;12:429-47. [DOI: 10.1016/j.mric.2004.03.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
394 Nagano Y, Shimada H, Ueda M, Matsuo K, Tanaka K, Endo I, Kunisaki C, Togo S. Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas. ANZ Journal of Surgery 2009;79:729-33. [DOI: 10.1111/j.1445-2197.2009.05059.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
395 Kim SH, Lim HK, Choi D, Lee WJ, Kim SH, Kim MJ, Kim CK, Jeon YH, Lee JM, Rhim H. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR Am J Roentgenol. 2006;186:S327-S333. [PMID: 16632696 DOI: 10.2214/ajr.05.0350] [Cited by in Crossref: 45] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
396 Itri JN, Heller MT, Tublin ME. Hepatic transplantation: postoperative complications. Abdom Imaging. 2013;38:1300-1333. [PMID: 23644931 DOI: 10.1007/s00261-013-0002-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
397 Adam R, Hoti E, Bredt LC. Evolution of neoadjuvant therapy for extended hepatic metastases-have we reached our (non-resectable) limit?: Neoadjuvant Therapy. J Surg Oncol 2010;102:922-31. [DOI: 10.1002/jso.21727] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
398 Bhardwaj N, Strickland AD, Ahmad F, Dennison AR, Lloyd DM. Liver ablation techniques: a review. Surg Endosc. 2010;24:254-265. [PMID: 19554370 DOI: 10.1007/s00464-009-0590-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
399 Verhoef C, Kuiper JW, Heisterkamp J, de Man RA, Pattynama PMT, Ijzermans JNM. Interstitial laser coagulation with temporary hepatic artery occlusion for patients with cirrhosis and irresectable hepatoma. British Journal of Surgery 2003;90:950-5. [DOI: 10.1002/bjs.4135] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
400 Kim GM, Won JY, Kim MD, Park SI, Lee do Y, Shin W, Shin M, Han KH, Kim do Y, Kim SU. Cryoablation of Hepatocellular Carcinoma with High-Risk for Percutaneous Ablation: Safety and Efficacy. Cardiovasc Intervent Radiol. 2016;39:1447-1454. [PMID: 27256103 DOI: 10.1007/s00270-016-1384-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
401 Cabibbo G, Craxì A. Needle track seeding following percutaneous procedures for hepatocellular carcinoma. World J Hepatol 2009;1:62-6. [PMID: 21160966 DOI: 10.4254/wjh.v1.i1.62] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
402 Coad JE, Kosari K, Humar A, Sielaff TD. Radiofrequency ablation causes 'thermal fixation' of hepatocellular carcinoma: a post-liver transplant histopathologic study. Clin Transplant 2003;17:377-84. [PMID: 12868996 DOI: 10.1034/j.1399-0012.2003.00062.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 2.7] [Reference Citation Analysis]
403 Mela M, Mancuso A, Burroughs AK. Review article: hepatocellular carcinoma: indications for liver transplantation. Aliment Pharmacol Ther. 2003;17 Suppl 2:130-137. [PMID: 12786624 DOI: 10.1046/j.1365-2036.17.s2.16.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
404 Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004;14:2261-7. [DOI: 10.1007/s00330-004-2416-z] [Cited by in Crossref: 112] [Cited by in F6Publishing: 94] [Article Influence: 6.6] [Reference Citation Analysis]
405 Sato K, Watanabe Y, Horiuchi A, Yukumi S, Doi T, Yoshida M, Yamamoto Y, Maehara T, Naohara T, Kawachi K. Novel tumor-ablation device for liver tumors utilizing heat energy generated under an alternating magnetic field. Journal of Gastroenterology and Hepatology 2008;23:1105-11. [DOI: 10.1111/j.1440-1746.2008.05328.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
406 Fonseca AZ, Santin S, Gomes LG, Waisberg J, Ribeiro MA Jr. Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors. World J Hepatol 2014;6:107-13. [PMID: 24672640 DOI: 10.4254/wjh.v6.i3.107] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
407 Frezza EE, Wachtel MS, Barragan B, Chiriva-internati M, Cobos E. The Role of Radiofrequency Ablation in Multiple Liver Metastases to Debulk the Tumor: A Pilot Study before Alternative Therapies. Journal of Laparoendoscopic & Advanced Surgical Techniques 2007;17:282-4. [DOI: 10.1089/lap.2006.0100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
408 Qin H, Gao P, Wang F, Zhao L, Zhu J, Wang A, Zhang T, Wu R, Zou H. Highly Efficient Extraction of Serum Peptides by Ordered Mesoporous Carbon. Angew Chem Int Ed 2011;50:12218-21. [DOI: 10.1002/anie.201103666] [Cited by in Crossref: 108] [Cited by in F6Publishing: 95] [Article Influence: 10.8] [Reference Citation Analysis]
409 Schwartz JM, Ham JM. Treatment of Hepatocellular Carcinoma. Curr Treat Options Gastroenterol 2003;6:465-72. [PMID: 14585235 DOI: 10.1007/s11938-003-0048-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
410 Scaife CL, Curley SA. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin N Am. 2003;12:243-255. [PMID: 12735142 DOI: 10.1016/s1055-3207(02)00088-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
411 Seinstra BA, van Delden OM, van Erpecum KJ, van Hillegersberg R, Mali WP, van den Bosch MA. Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today? Insights Imaging. 2010;1:167-181. [PMID: 23100194 DOI: 10.1007/s13244-010-0027-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
412 Lam VW, Ng KK, Chok KS, Cheung TT, Wat J, Fan ST, Poon RT. Safety and efficacy of radiofrequency ablation for periductal hepatocellular carcinoma with intraductal cooling of the central bile duct. J Am Coll Surg 2008;207:e1-5. [PMID: 18656036 DOI: 10.1016/j.jamcollsurg.2008.03.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
413 Tsai W, Cheng J, Lai K, Lin C, Lo G, Hsu P, Yu H, Lin C, Chan H, Chen W, Chen T, Li W, Liang H. Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma - a long-term follow-up study. Alimentary Pharmacology & Therapeutics 2008;28:304-11. [DOI: 10.1111/j.1365-2036.2008.03702.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
414 Ng KK, Poon RT. Role of radiofrequency ablation for liver malignancies. Surgical Practice 2005;9:94-103. [DOI: 10.1111/j.1744-1633.2005.00265.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
415 Gaiani S, Celli N, Cecilioni L, Piscaglia F, Bolondi L. Percutaneous treatment of hepatocellular carcinoma: REVIEW: PERCUTANEOUS TREATMENT OF HEPATOCELLULAR CARCINOMA. Alimentary Pharmacology & Therapeutics 2003;17:103-10. [DOI: 10.1046/j.1365-2036.17.s2.21.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
416 Sakata J, Shirai Y, Wakai T, Kaneko K, Hatakeyama K. Long-term outcomes after hepatectomy for recurrences after prior local ablation for hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO) 2008;34:433-8. [DOI: 10.1016/j.ejso.2007.03.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
417 Midorikawa Y, Takayama T, Shimada K, Nakayama H, Higaki T, Moriguchi M, Nara S, Tsuji S, Tanaka M. Marginal survival benefit in the treatment of early hepatocellular carcinoma. J Hepatol. 2013;58:306-311. [PMID: 23063418 DOI: 10.1016/j.jhep.2012.09.026] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
418 Kawamura Y, Ikeda K, Fukushima T, Hara T, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H. Potential of a no-touch pincer ablation procedure for small hepatocellular carcinoma that uses a multipolar radiofrequency ablation system: An experimental animal study: No-touch ablation procedure for hepatic tumors. Hepatol Res 2014;44:1234-40. [DOI: 10.1111/hepr.12240] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
419 Tung WC, Huang YJ, Leung SW, Kuo FY, Tung HD, Wang JH, Hung CH, Lee CM, Changchien CS, Yeh SA. Incidence of needle tract seeding and responses of soft tissue metastasis by hepatocellular carcinoma postradiotherapy. Liver Int. 2007;27:192-200. [PMID: 17311613 DOI: 10.1111/j.1478-3231.2006.01399.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
420 Jain D. Tissue diagnosis of hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4:S67-S73. [PMID: 25755614 DOI: 10.1016/j.jceh.2014.03.047] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
421 Onik G, Onik C, Medary I, Berridge DM, Chicks DS, Proctor LT, Winter TC 3rd, Lee FT Jr. Life-threatening hypertensive crises in two patients undergoing hepatic radiofrequency ablation. AJR Am J Roentgenol 2003;181:495-7. [PMID: 12876033 DOI: 10.2214/ajr.181.2.1810495] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
422 Kang TW, Lim HK, Lee MW, Kim YS, Choi D, Rhim H. First-line radiofrequency ablation with or without artificial ascites for hepatocellular carcinomas in a subcapsular location: local control rate and risk of peritoneal seeding at long-term follow-up. Clin Radiol 2013;68:e641-51. [PMID: 23973161 DOI: 10.1016/j.crad.2013.07.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
423 Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519-524. [PMID: 11870363 DOI: 10.1053/jhep.2002.32089] [Cited by in Crossref: 801] [Cited by in F6Publishing: 735] [Article Influence: 42.2] [Reference Citation Analysis]
424 Curley SA, Marra P, Beaty K, Ellis LM, Vauthey JN, Abdalla EK, Scaife C, Raut C, Wolff R, Choi H, Loyer E, Vallone P, Fiore F, Scordino F, De Rosa V, Orlando R, Pignata S, Daniele B, Izzo F. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004;239:450-458. [PMID: 15024305 DOI: 10.1097/01.sla.0000118373.31781.f2] [Cited by in Crossref: 278] [Cited by in F6Publishing: 218] [Article Influence: 16.4] [Reference Citation Analysis]
425 Helton WS, Di Bisceglie A, Chari R, Schwartz M, Bruix J. Treatment strategies for hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2003;7:401-11. [PMID: 12654567 DOI: 10.1016/s1091-255x(02)00161-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
426 Kim KR, Thomas S. Complications of image-guided thermal ablation of liver and kidney neoplasms. Semin Intervent Radiol. 2014;31:138-148. [PMID: 25049443 DOI: 10.1055/s-0034-1373789] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
427 Steinke K. Radiofrequency Ablation (RFA). In: Vogl TJ, Helmberger TK, Mack MG, Reiser MF, editors. Percutaneous Tumor Ablation in Medical Radiology. Berlin: Springer Berlin Heidelberg; 2008. pp. 179-96. [DOI: 10.1007/978-3-540-68250-9_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
428 Winter TC, Laeseke PF, Lee FT Jr. Focal tumor ablation: a new era in cancer therapy. Ultrasound Q 2006;22:195-217. [PMID: 16957613 DOI: 10.1097/01.ruq.0000232614.79547.b6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
429 Kumar N, Gaba RC, Knuttinen MG, Omene BO, Martinez BK, Owens CA, Bui JT. Tract seeding following radiofrequency ablation for hepatocellular carcinoma: prevention, detection, and management. Semin Intervent Radiol 2011;28:187-92. [PMID: 22654260 DOI: 10.1055/s-0031-1280662] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
430 Yamakado K, Nakatsuka A, Takaki H, Sakurai H, Isaji S, Yamamoto N, Shiraki K, Takeda K. Subphrenic versus nonsubphrenic hepatocellular carcinoma: combined therapy with chemoembolization and radiofrequency ablation. AJR Am J Roentgenol. 2010;194:530-535. [PMID: 20093620 DOI: 10.2214/ajr.09.2917] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
431 Kornberg A, Witt U, Schernhammer M, Kornberg J, Ceyhan GO, Mueller K, Friess H, Thrum K. Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma. Sci Rep. 2017;7:14176. [PMID: 29074969 DOI: 10.1038/s41598-017-14430-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
432 Adam R, Del Gaudio M. Evolution of liver transplantation for hepatocellular carcinoma. J Hepatol. 2003;39:888-895. [PMID: 14642602 DOI: 10.1016/j.jhep.2003.10.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
433 Liu CY, Chen KF, Chen PJ. Treatment of Liver Cancer. Cold Spring Harb Perspect Med 2015;5:a021535. [PMID: 26187874 DOI: 10.1101/cshperspect.a021535] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 14.2] [Reference Citation Analysis]
434 Kim TH, Choi HI, Kim BR, Kang JH, Nam JG, Park SJ, Lee S, Yoon JH, Lee DH, Joo I, Lee JM. No-Touch Radiofrequency Ablation of VX2 Hepatic Tumors In Vivo in Rabbits: A Proof of Concept Study. Korean J Radiol 2018;19:1099-109. [PMID: 30386141 DOI: 10.3348/kjr.2018.19.6.1099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
435 Schwartz M, Roayaie S, Uva P. Treatment of HCC in patients awaiting liver transplantation. Am J Transplant. 2007;7:1875-1881. [PMID: 17532747 DOI: 10.1111/j.1600-6143.2007.01863.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
436 Mori Y, Tamai H, Shingaki N, Moribata K, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Terada M, Ichinose M. Signal intensity of small hepatocellular carcinoma on apparent diffusion coefficient mapping and outcome after radiofrequency ablation: ADC mapping and outcome after RFA. Hepatol Res 2015;45:75-87. [DOI: 10.1111/hepr.12311] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
437 Lubienski A, Leibecke T, Lubienski K, Helmberger T. Liver metastases. Recent Results Cancer Res. 2006;167:79-89. [PMID: 17044298 DOI: 10.1007/3-540-28137-1_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
438 Iwamoto T, Kawai N, Sato M, Tanihata H, Takasaka I, Minamiguchi H, Sahara S, Nakata K, Shirai S. Effectiveness of hepatic arterial embolization on radiofrequency ablation volume in a swine model: relationship to portal venous flow and liver parenchymal pressure. J Vasc Interv Radiol 2008;19:1646-51. [PMID: 18954767 DOI: 10.1016/j.jvir.2008.08.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
439 Rakha E, Ramaiah S, McGregor A. Accuracy of frozen section in the diagnosis of liver mass lesions. J Clin Pathol 2006;59:352-4. [PMID: 16489181 DOI: 10.1136/jcp.2005.029538] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
440 Benson AB 3rd, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, Are C, Brown DB, Chang DT, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Schmidt C, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Zhu AX, Hoffmann KG, Darlow S. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. J Natl Compr Canc Netw. 2017;15:563-573. [PMID: 28476736 DOI: 10.6004/jnccn.2017.0059] [Cited by in Crossref: 155] [Cited by in F6Publishing: 135] [Article Influence: 38.8] [Reference Citation Analysis]
441 Galun D, Basaric D, Zuvela M, Bulajic P, Bogdanovic A, Bidzic N, Milicevic M. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World J Hepatol. 2015;7:2274-2291. [PMID: 26380652 DOI: 10.4254/wjh.v7.i20.2274] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
442 Primrose JN. Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation. Gut 2002;50:1-5. [PMID: 11772955 DOI: 10.1136/gut.50.1.1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 3.2] [Reference Citation Analysis]
443 van Duijnhoven FH, Jansen MC, Junggeburt JM, van Hillegersberg R, Rijken AM, van Coevorden F, van der Sijp JR, van Gulik TM, Slooter GD, Klaase JM. Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol. 2006;13:651-658. [PMID: 16538411 DOI: 10.1245/aso.2006.08.014] [Cited by in Crossref: 91] [Cited by in F6Publishing: 31] [Article Influence: 6.1] [Reference Citation Analysis]
444 Song KD, Rhim H, Lee MW, Kang TW, Lim S. A radiofrequency device for tract ablation after liver biopsy: a single-institution human feasibility study. Br J Radiol 2018;91:20170585. [PMID: 29356562 DOI: 10.1259/bjr.20170585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
445 Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST. Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol. 2004;11:281-289. [PMID: 14993023 DOI: 10.1245/ASO.2004.08.018] [Cited by in Crossref: 66] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
446 Maturen KE, Nghiem HV, Marrero JA, Hussain HK, Higgins EG, Fox GA, Francis IR. Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. AJR Am J Roentgenol. 2006;187:1184-1187. [PMID: 17056903 DOI: 10.2214/ajr.05.1347] [Cited by in Crossref: 95] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
447 Llovet JM. Evidence-based medicine in the treatment of hepatocellular carcinoma: Evidence-based treatment of HCC. Journal of Gastroenterology and Hepatology 2002;17:S428-33. [DOI: 10.1046/j.1440-1746.17.s3.40.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]